Original Article
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
N Engl J Med 2004; 351:427-437July 29, 2004
- Abstract
Background
The value of regular surveillance for breast cancer in women with a genetic or familial predisposition to breast cancer is currently unproven. We compared the efficacy of magnetic resonance imaging (MRI) with that of mammography for screening in this group of high-risk women.
Methods
Women who had a cumulative lifetime risk of breast cancer of 15 percent or more were screened every six months with a clinical breast examination and once a year by mammography and MRI, with independent readings. The characteristics of the cancers that were detected were compared with the characteristics of those in two different age-matched control groups.
Results
We screened 1909 eligible women, including 358 carriers of germ-line mutations. Within a median follow-up period of 2.9 years, 51 tumors (44 invasive cancers, 6 ductal carcinomas in situ, and 1 lymphoma) and 1 lobular carcinoma in situ were detected. The sensitivity of clinical breast examination, mammography, and MRI for detecting invasive breast cancer was 17.9 percent, 33.3 percent, and 79.5 percent, respectively, and the specificity was 98.1 percent, 95.0 percent, and 89.8 percent, respectively. The overall discriminating capacity of MRI was significantly better than that of mammography (P<0.05). The proportion of invasive tumors that were 10 mm or less in diameter was significantly greater in our surveillance group (43.2 percent) than in either control group (14.0 percent [P<0.001] and 12.5 percent [P=0.04], respectively). The combined incidence of positive axillary nodes and micrometastases in invasive cancers in our study was 21.4 percent, as compared with 52.4 percent (P<0.001) and 56.4 percent (P=0.001) in the two control groups.
Conclusions
MRI appears to be more sensitive than mammography in detecting tumors in women with an inherited susceptibility to breast cancer.
Media in This Article
Figure 1
Women at Increased Risk for Breast Cancer Enrolled and Tumors Detected.Figure 2
Receiver-Operating-Characteristic Curves for Mammography and MRI.Article Activity
- Article
The cumulative lifetime risk of breast cancer among Dutch women is approximately 11 percent.1 A family history of breast cancer or the presence of a germ-line mutation of the BRCA1 or BRCA2 gene increases this risk considerably and is often associated with a diagnosis at a young age.2,3 Among high-risk women, the risk of breast cancer can be reduced by prophylactic mastectomy,4,5 prophylactic oophorectomy,6,7 or chemoprevention.8 Early diagnosis as a result of intensive surveillance may also decrease the rate of death from breast cancer.
Randomized trials have shown that mammographic screening of all women who are between 50 and 70 years of age can reduce mortality from breast cancer by about 25 percent.9 Although these findings were recently disputed,10 there is a consensus among clinicians that breast-cancer screening of women in this age group is effective. Screening is one of the main factors contributing to the decrease in mortality associated with breast cancer in the Netherlands.11 However, there is no consensus about the value of breast-cancer screening among women who are 40 to 49 years old.12-14 One of the reasons for the lack of agreement is the difficulty in detecting tumors by mammographic screening in younger women, who have denser breasts than postmenopausal women.15,16 Although screening is frequently offered to women with a genetic predisposition to breast cancer who are under the age of 50 years, the efficacy of this approach is unproven. Preliminary results of surveillance by mammography and clinical breast examination in such women showed that mammographic screening has a low sensitivity for detecting tumors, especially in carriers of a BRCA mutation.17-21 Possible reasons, apart from the high rate of growth of tumors in women with such mutations, include the atypical changes seen on screening mammograms and specific histopathological characteristics in carriers of BRCA mutations, as compared with noncarriers of the same age.22-24
In a diagnostic setting, magnetic resonance imaging (MRI) is a sensitive method of breast imaging, and it is virtually uninfluenced by breast density, but the specificity is variable and the costs are high.25-27 Because MRI may improve the sensitivity of screening in women with a familial or genetic predisposition to breast cancer, we prospectively compared MRI with mammography for screening women with such a predisposition in order to determine whether screening with MRI facilitated the early diagnosis of hereditary breast cancer.
Methods
Study Population
The design of our MRI screening study, in which six subcommittees in different disciplines were involved, has been described previously.28 Between November 1, 1999, and October 1, 2003, 1952 women with a genetic risk of breast cancer were recruited for the study by six familial-cancer clinics in the Netherlands. The six centers were Erasmus Medical Center–Daniel den Hoed Cancer Center, Rotterdam; the Netherlands Cancer Institute, Amsterdam; University Medical Center Nijmegen, Nijmegen; Leiden University Medical Center, Leiden; University Hospital Groningen, Groningen; and Free University Medical Center, Amsterdam. The study was approved by the ethics committees of all the centers. All the women who participated gave written informed consent.
The inclusion criteria for participation were a cumulative lifetime risk of breast cancer of 15 percent or more owing to a familial or genetic predisposition, according to the modified tables of Claus et al.,29 and an age of 25 to 70 years. Women could be tested at an age younger than 25 if they had a family history of breast cancer diagnosed before the age of 30 years, since testing began at an age 5 years younger than that at which the youngest family member was found to have breast cancer. Women with symptoms that were suggestive of breast cancer or women who had a personal history of breast cancer were excluded.
Surveillance
Surveillance consisted of a clinical breast examination performed by an experienced physician every six months and imaging studies performed annually by experienced radiologists. The imaging included a mammographic study (oblique and craniocaudal views and, if necessary, compression views or magnifications) and a dynamic breast MRI with gadolinium-containing contrast medium according to a standard protocol.25 Whenever possible, both imaging investigations were performed on the same day or in the same time period, between day 5 and day 15 of the menstrual cycle. The results of mammography and MRI were scored in a standardized way, according to the Breast Imaging Reporting and Data System (BI-RADS) classification,30,31 and the results were blinded so that the two examinations were not linked. When one of the examinations was scored as either BI-RADS category 3 (“probably benign [i.e., uncertain] finding”) or category 0 (“need additional imaging evaluation”), further investigation by ultrasonography with or without fine-needle aspiration was advised, or mammography or MRI was repeated. When one of the two examinations was scored as BI-RADS category 4 (“suspicious abnormality”) or category 5 (“highly suggestive of malignancy”), a cytologic or histologic evaluation of a biopsy specimen was performed. When the results of mammography and MRI were negative but the findings on clinical breast examination were rated as uncertain or suspicious, additional investigation was also performed. The diagnosis of malignant tumors was based on the results of a histologic examination. One of the investigators, an expert pathologist, reviewed all the biopsy specimens that formed the basis for the diagnosis of breast cancer.
Statistical Analysis
The women were divided into three categories according to the cumulative lifetime risk of breast cancer, as follows: carriers of the BRCA1 or BRCA2 or other mutations (cumulative lifetime risk, 50 to 85 percent), a high-risk group (risk, 30 to 49 percent), and a moderate-risk group (risk, 15 to 29 percent).28,29 The characteristics of the women in each risk group were compared by analysis of variance or Pearson's chi-square test.
The rates of detection of breast cancer for the group as a whole and for each of the three risk groups were calculated, and a Poisson distribution was assumed in order to calculate the 95 percent confidence intervals. Person-years at risk were calculated from the date of the first examination, irrespective of the type of examination, to the date of detection of breast cancer, bilateral prophylactic mastectomy, or death; the date that a patient stopped surveillance; or the cutoff date for this analysis (October 1, 2003). An “interval cancer” was defined as a carcinoma detected between two rounds of screening after initially negative findings on screening. In our analysis, we defined as positive a mammographic or MRI study with a BI-RADS score of 0, 3, 4, or 5 and a clinical breast examination that was classified as “uncertain” or “suspicious,” because those were the results that triggered an additional examination.
To compare the three different screening methods, we calculated the sensitivity, specificity, and positive predictive value of each. The sensitivity used is that of one screening method relative to the others, meaning that a test result is a false negative when a proven cancer (diagnosed on the basis of a histologic examination) is detected in the interval or by one of the other methods. Receiver-operating-characteristic (ROC) curves for the two imaging methods were generated. The area under the curve was used as an index in evaluating the inherent capacity of a screening method to discriminate between “positive” and “negative” cases. We used a z-test to compare the area under the curve for the results of mammography and MRI. For the analysis of the screening variables, we used only the screening data that included the results of both mammography and MRI.
To determine whether breast cancer was diagnosed by screening at a stage more favorable to treatment, the characteristics of breast tumors detected in the study group were compared with those in two control groups. The first control group was derived from all women who had breast cancers diagnosed in 1998 in the Netherlands. These data were obtained from the National Cancer Registry. The second control group consisted of unselected patients who had received a diagnosis of primary breast cancer in Leiden or Rotterdam between 1996 and 2002 and who were participating in a prospective study of the prevalence of gene mutations.32 Subjects in both control groups were matched for age with the patients in the study group (in five-year categories). From this series of consecutive patients in the second control group, we chose all the unscreened patients who were between 25 and 60 years old and whose cumulative lifetime risk of breast cancer was more than 15 percent because of a family history of the disease — information that was routinely recorded in this database. The differences in tumor characteristics between the study group and the control groups were tested with the use of Pearson's chi-square test or the chi-square test for trend. A two-sided P value of less than 0.05 was considered to indicate statistical significance. All statistical analyses were performed with the use of SPSS software (version 9.0).
Results
Study Population
Of the women who were invited to participate in the study, 90 percent agreed. Initially, 1952 women were included; 8 withdrew from the study before their first screening visit and another 35 were excluded because they ultimately proved not to be carriers in a family with a proven mutation and therefore had less than a 15 percent cumulative lifetime risk of breast cancer. Of the 1909 remaining women, 88 (4.6 percent) left the study or were lost to surveillance before October 1, 2003; 65 of these 88 women underwent prophylactic mastectomy. Another 89 women (4.7 percent) remained under surveillance but later refused screening by MRI, because of claustrophobia or for other reasons.
Table 1Table 1
Characteristics of Participating Women at Study Entry, According to Risk Group. lists the characteristics of the 1909 women according to risk category. The mean age at entry was 40 years (range, 19 to 72). Within the group of 358 carriers of pathogenic mutations, 276 had a BRCA1 mutation, 77 had a BRCA2 mutation, 1 had both a BRCA1 and a BRCA2 mutation, 2 had a PTEN mutation, and 2 had a TP53 mutation.Breast Cancers
From November 1, 1999, to October 1, 2003, 51 malignant tumors (44 invasive breast cancers, 6 ductal carcinomas in situ, and 1 non-Hodgkin's lymphoma) were detected (Figure 1Figure 1
Women at Increased Risk for Breast Cancer Enrolled and Tumors Detected.), during a median follow-up period of 2.9 years (mean 2.7, range, 0.1 to 3.9 years); 1 lobular carcinoma in situ was also found. Table 2Table 2
Detection of Cases of Breast Cancer (Including Ductal Carcinoma in Situ) According to Risk Group. shows the detection rate for the whole group and separately for the different risk groups. The overall rate of detection for all breast cancers (invasive plus in situ) was 9.5 per 1000 woman-years at risk (95 percent confidence interval, 7.1 to 12.3), with the highest rate (26.5 per 1000) in the group of women who were carriers of the BRCA1, BRCA2, PTEN, and TP53 mutations.Performance of the Screening Methods
Table 3Table 3
Sensitivity, Specificity, and Positive Predictive Value (PPV) of the Three Screening Methods. shows the results with the three screening methods. Of the 50 breast cancers that were detected, 5 were excluded from the analysis (Table 3). The 45 cancers that were evaluated in the comparison of the methods included 4 interval cancers (i.e., cancers detected between two episodes of screening). The first was symptomatic (30 mm in diameter, node-negative), detected seven months after screening by imaging and clinical breast examination and one month after screening by clinical breast examination only. The second (4 mm, node-negative) was detected in a specimen from a prophylactic mastectomy. The third was symptomatic (45 mm, node-negative) and was detected seven months after screening by imaging; the fourth, also symptomatic (13 mm, with isolated tumor cells in a lymph node), was detected three months after screening by imaging.Overall, 32 breast cancers were found by MRI (22 of these were not visible on mammography), whereas 13 were missed by MRI (8 of the 13 were visible on mammography, including 5 ductal carcinomas in situ; 4 were interval cancers; and 1 tumor was detected only by clinical breast examination). In this group of 45 breast cancers, mammographic screening detected 18 tumors (10 of these were visible by MRI) and missed 27 tumors (including the 22 that were visible on MRI, the 4 interval cancers, and the 1 that was detected only by clinical breast examination).
With respect to all breast cancers (invasive and ductal carcinoma in situ), the sensitivity of clinical breast examination, mammography, and MRI was 17.8 percent, 40.0 percent, and 71.1 percent, respectively, when the BI-RADS score was 3 or higher (Table 3). For invasive cancers only, the respective percentages were 17.9 percent, 33.3 percent, and 79.5 percent. The specificity was 98.1 percent for clinical breast examination, 95.0 percent for mammography, and 89.8 percent for MRI.
Of the 41 cancers found by screening, 22 were detected at the first imaging screening in the study; of the women in whom cancer was detected, 16 had undergone mammographic screening before the start of the study. Two of the interval cancers were detected after the first imaging screening, and two others after a subsequent imaging screening. The sensitivity of mammography was 37.5 percent for the first screening and 42.9 percent for subsequent screening (P=0.71). The sensitivity of MRI was 79.2 percent for the first screening and 61.9 percent for subsequent screening (P=0.20).
Among the 83 clinical breast examinations with findings that were judged as probably benign or suspicious, or highly suggestive of cancer, 8 cases of malignant disease were confirmed, for a positive predictive value of 9.6 percent (Table 3). Among the 225 mammograms with findings categorized as BI-RADS 3 or higher, 18 cases of malignant disease were confirmed, for a positive predictive value of 8.0 percent. A total of 32 cancers were confirmed among 452 MRI screenings with such findings, for a positive predictive value of 7.1 percent (Table 3). With a cutoff level of BI-RADS 4, the sensitivity for both imaging methods decreased, whereas the specificity increased.
To evaluate the discriminating capacity of the imaging methods, we generated ROC curves (Figure 2Figure 2
Receiver-Operating-Characteristic Curves for Mammography and MRI.). The area under the curve was 0.686 for mammography and 0.827 for MRI; the difference between the areas was 0.141 (95 percent confidence interval, 0.020 to 0.262; P<0.05).Additional Investigations
Ultrasonography was performed 889 times in 627 different women according to the protocol. Fine-needle aspiration was carried out 312 times: 267 times in combination with ultrasonography and 45 times with palpation. Biopsy was performed 85 times in 82 women and showed malignant disease in 50 cases and 1 lobular carcinoma in situ, making the rate of positive histologic findings 60.0 percent. Sixty-seven of these 85 biopsies were performed after a screening visit at which both MRI and mammography were performed. Of the 25 biopsies in women who had mammographic findings with a score of 3 or higher, 7 (28.0 percent) showed no cancer. Of the 56 biopsies in women who had MRI findings with a score of 3 or higher, 24 (42.9 percent) showed no cancer (Table 3). One of the 51 tumors was found in a specimen from a prophylactic mastectomy.
Tumor Characteristics
Table 4Table 4
Characteristics of Women with Breast Cancer and Breast Cancers Detected in the Three Risk Groups and in the Two Control Groups. compares the characteristics of tumors found in the study group with those of tumors in the two age-matched control groups. In the study group, 19 of the 44 women with an invasive breast cancer (43.2 percent) had a small tumor (≤10 mm in diameter) — a proportion that was significantly higher than that in the first control group (14.0 percent, P<0.001) or the second control group (12.5 percent, P=0.04). Six of 42 invasive tumors (14.3 percent) with known axillary status in the study group were node-positive and 3 (7.1 percent) had micrometastases (combined total, 21.4 percent). This rate was significantly lower than those in both control groups, in which the rates of node-positive cancer were 52.4 percent (P<0.001) and 56.4 percent (P=0.001), respectively. There were no major differences between the study and control groups with respect to histologic features, with the exception of a relatively high incidence of the medullary type in the study group (11.3 percent, vs. 1.8 percent in the first control group). In the study group, a high proportion of grade 1 tumors were in women at high risk (68.8 percent) or moderate risk (75.0 percent); however, the group of women with BRCA1, BRCA2, or other mutations had a high percentage of grade 3 tumors (63.2 percent), in addition to a high percentage of tumors that were negative for steroid receptors (Table 4).Disease-free and Overall Survival
In the study group, none of the 50 patients with breast cancer (44 with invasive cancer and 6 with ductal carcinoma in situ) died before the end of the study period; the total follow-up after diagnosis was 87.6 woman-years for these 50 patients (median, 1.5 years). Contralateral breast cancer occurred in one patient. The patient with non-Hodgkin's lymphoma died.
Discussion
In this prospective study, we compared the efficacy of mammographic and MRI screening for breast cancer in women with a family history of the disease or a genetic predisposition to breast cancer. Among the women examined by both methods at the same screening visit, we detected 45 breast cancers (including 6 ductal carcinomas in situ): 32 by MRI (sensitivity, 71.1 percent) and 18 by mammography (40.0 percent); five other patients were excluded from this comparison for various reasons (Table 3). Thus, the sensitivity of MRI was higher than that of mammography, but both the specificity and positive predictive value of MRI were lower.
In our sensitivity and specificity calculations, we defined lesions that were in BI-RADS category 3 and higher as positive, but most other authors have included in their calculations only lesions in BI-RADS categories 4 and 5 as positive.21,33,34 If we had followed that policy, the sensitivity would have been 24.4 percent for mammography and 46.6 percent for MRI, in accord with the higher sensitivity previously reported for MRI.21,33,35,36 However, the previous studies enrolled small groups of women, included some retrospective data,35 evaluated heterogeneous groups that included women with previous breast cancers,21,33,36 or had a plan for follow-up after a suspicious finding on MRI that differed from the follow-up plan for a suspicious mammographic finding.33 All these factors might have artificially increased the sensitivity of MRI. We also investigated sensitivity in relation to specificity as determined by ROC curves, showing that the area under the curve was significantly higher for MRI than for mammography; this means that MRI screening could better discriminate between malignant and benign cases.
When we included only invasive breast cancers, the difference between the sensitivity of the MRI and mammography (79.5 percent vs. 33.3 percent) was even greater than the difference overall (71.1 percent vs. 40.0 percent). MRI detected 20 cancers (including 1 ductal carcinoma in situ) that were not found by mammography or clinical breast examination. The stage of these 20 cancers was favorable; 11 of the 19 invasive tumors were smaller than 10 mm, and only 1 was associated with a positive node.
Another important matter that we addressed was the best method for detecting carcinoma in situ. Our study showed that mammography had a higher sensitivity than MRI for detecting ductal carcinoma in situ: 83 percent (five out of six cancers detected), as compared with 17 percent (one out of six) for MRI (P=0.22).
To investigate whether screening improves the chance of diagnosing breast cancer at an early stage, we compared the distribution of tumor stages in our study with the distribution in two external control groups. The first group consisted of age-matched women in a database of all breast cancers diagnosed in 1998 in the Netherlands. A drawback of this group is that we had no information about whether or not they had been screened or the family history. Therefore, we added a second control group from a prospective population-based study of the prevalence of mutations in patients with breast cancer. From this group, we selected all patients with an age and a family history of breast cancer that were similar to the women in our surveillance study. The tumors in our study group were significantly smaller and were less likely to be node-positive than those in the two control groups. Most screening studies (without MRI) in high-risk women have shown a higher incidence of positive nodes (30 to 45 percent) than we found (21 percent).17,18,37 Moreover, Kollias et al.38 found no significant differences in the size or grade of invasive tumors or in lymph-node status between women who had symptoms of cancer and women whose cancers had been found on screening by mammography. So we may conclude that MRI screening did indeed contribute to the early detection of hereditary breast cancer.
However, larger tumors (>2 cm in diameter) were found more often in the women with BRCA1, BRCA2, PTEN, and TP53 mutations than in the other two risk groups in our study, suggesting that more frequent screening is needed for women with these mutations. A drawback of MRI screening is that it has a lower specificity than mammography, and as a result, MRI will generate more findings judged as uncertain, which require short-term follow-up or additional investigations.39 In our study, screening by MRI led to twice as many unneeded additional examinations as did mammography (420 vs. 207) and three times as many unneeded biopsies (24 vs. 7).
In conclusion, our study shows that the screening program we used, especially MRI screening, can detect breast cancer at an early stage in women at risk for breast cancer.
Supported by a grant (OG 98-03) from the Dutch Health Insurance Council.
We are indebted to Petra Bos, Titia van Echten, Irene Groot, Marijke Hogenkamp, Arjan Nieborg, Angelique Schlief, and Manita Verhoeven for data collection; to Leon Aronson for computer assistance; and to Truuske de Bock and Ronald Damhuis for help in selecting the control groups.
Source Information
From the Rotterdam Family Cancer Clinic, Department of Medical Oncology (M.K., C.T.M.B., J.G.M.K.), and the Departments of Radiology (I.M.O.) and Surgery (M.M.A.T.-L.), Erasmus Medical Center–Daniel den Hoed Cancer Center, Rotterdam; the Department of Radiology (C.B.) and the Department of Medical Oncology and Family Cancer Clinic (L.V.A.M.B.), University Medical Center Nijmegen, Nijmegen; the Departments of Radiology (P.E.B., S.H.M.), Pathology (H.P.), and Surgery (E.J.T.R.), Netherlands Cancer Institute, Amsterdam; the Departments of Radiology (H.M.Z.) and Surgery (R.A.E.M.T.), Leiden University Medical Center, Leiden; the Departments of Radiology (R.A.M.) and Surgery (S.M.), Free University Medical Center, Amsterdam; the Departments of Radiology (T.K.) and Clinical Genetics (J.C.O.), University Hospital Groningen, Groningen; and the Department of Public Health, Erasmus Medical Center, Rotterdam (H.J.K.) — all in the Netherlands.
Address reprint requests to Dr. Klijn at Erasmus Medical Center–Daniel den Hoed Cancer Center, Groene Hilledijk 301 3075 EA, Rotterdam, the Netherlands, or at j.g.m.klijn@erasmusmc.nl.
Other investigators in the Magnetic Resonance Imaging Screening (MRISC) study are listed in the Appendix.
Appendix
In addition to the authors, the following investigators participated in the MRISC Study: Erasmus Medical Center, Rotterdam — C.C.M. Bartels, A. Ciurea, A.N. van Geel, E.J. Meijers-Heijboer, M. Menke, A.J. Rijnsburger, C. Seynaeve, D. Urich; Leiden University Medical Center, Leiden — C. van Asperen, M.N.J.M. Wasser; Netherlands Cancer Institute, Amsterdam — R. Kaas, W. Koops, M. Piek-den Hartog, M. van de Vijver; University Hospital Groningen, Groningen — C. Dorbritz, S. van Hoof, A.M. van der Vliet, J. de Vries; University Medical Center Nijmegen, Nijmegen — J.O. Barentsz, H. Brunner, J.H.C.L. Hendriks, R. Holland, N. Hoogerbrugge, M. Stoutjesdijk, A.L.M. Verbeek, T. Wobbes; Free University Medical Center, Amsterdam — F. Menko, A. Taets van Amerongen.
- References
References
1
Visser O, Coebergh JWW, van Dijck JAAM, et al., eds. Incidence of cancer in the Netherlands 1998. Utrecht, the Netherlands: Netherlands Cancer Registry, 2002.
2
Ford D ,Easton DF ,Stratton M , et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998;62:676-689
CrossRef | Web of Science | Medline3
Klijn JGM ,Meijers-Heijboer H . Gene screening and prevention of hereditary breast cancer: a clinical view. Eur J Cancer Suppl 2003;1:13-234
Hartmann LC ,Sellers TA ,Schaid DJ , et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001;93:1633-1637
CrossRef | Web of Science | Medline5
Meijers-Heijboer H ,van Geel B ,van Putten WLJ , et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001;345:159-164
Full Text | Web of Science | Medline6
Rebbeck TR ,Lynch HT ,Neuhausen SL , et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-1622
Full Text | Web of Science | Medline7
Kauff ND ,Satagopan JM ,Robson ME , et al. Risk-reduction salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002;346:1609-1615
Full Text | Web of Science | Medline8
Cuzick J ,Powels T ,Veronesi U , et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet 2003;361:296-300
CrossRef | Web of Science | Medline9
Nystrom L ,Andersson I ,Bjurstam N ,Frisell J ,Nordenskjold B ,Rutqvist LE . Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-919[Erratum, Lancet 2002;360:724.]
CrossRef | Web of Science | Medline10
Olsen O ,Gotzsche PC . Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-1342
CrossRef | Web of Science | Medline11
Otto SJ ,Fracheboud J ,Looman CWN , et al. Initiating of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003;361:1411-1417
CrossRef | Web of Science | Medline12
de Koning HJ ,Boer R ,Warmerdam PG ,Beemsterboer PM ,van der Maas PJ . Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. J Natl Cancer Inst 1995;87:1217-1223
CrossRef | Web of Science | Medline13
Breast-cancer screening with mammography in women aged 40-49 years. Int J Cancer 1996;68:693-699
CrossRef | Web of Science | Medline14
Elmore JG ,Barton MB ,Moceri VM ,Polk S ,Arena PJ ,Fletcher SW . Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998;338:1089-1096
Full Text | Web of Science | Medline15
Kolb TM ,Lichy J ,Newhouse JH . Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 2002;225:165-175
CrossRef | Web of Science | Medline16
Mandelson MT ,Oestreicher N ,Porter PL , et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000;92:1081-1087
CrossRef | Web of Science | Medline17
Brekelmans CTM ,Seynaeve C ,Bartels CCM , et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high family risk. J Clin Oncol 2001;19:924-930
Web of Science | Medline18
Chart PL ,Franssen E . Management of women at increased risk for breast cancer: preliminary results from a new program. CMAJ 1997;157:1235-1242
Web of Science | Medline19
Macmillan RD . Screening women with a familial history of breast cancer -- results from the British Familial Breast Cancer Group. Eur J Surg Oncol 2000;26:149-152
CrossRef | Web of Science | Medline20
Scheuer L ,Kauff N ,Robson M , et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 2002;20:1260-1268
CrossRef | Web of Science | Medline21
Warner E ,Plewes DB ,Shumak RS , et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001;19:3524-3531
Web of Science | Medline22
Tilanus-Linthorst M ,Verhoog L ,Obdeijn IM , et al. A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer 2002;102:91-95[Erratum, Int J Cancer 2002;102:665.]
CrossRef | Web of Science | Medline23
Huo Z ,Giger ML ,Olopade OI , et al. Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. Radiology 2002;225:519-526
CrossRef | Web of Science | Medline24
Adem C ,Reynolds C ,Soderberg CL , et al. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer 2003;97:1-11
CrossRef | Web of Science | Medline25
Boetes C ,Stoutjesdijk M . MR imaging in screening women at increased risk for breast cancer. Magn Reson Imaging Clin N Am 2001;9:357-372
Medline26
Morris EA . Review of breast MRI: indications and limitations. Semin Roentgenol 2001;36:226-237
CrossRef | Web of Science | Medline27
Orel SG ,Schnall MD . MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220:13-30
Web of Science | Medline28
Kriege M ,Brekelmans CTM ,Boetes C , et al. MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC). Fam Cancer 2001;1:163-168
CrossRef | Medline29
Claus EB ,Risch N ,Thompson WD . Autosomal dominant inheritance of early-onset breast cancer: implications for risk prediction. Cancer 1994;73:643-651
CrossRef | Web of Science | Medline30
Illustrated Breast Imaging Reporting and Data System (BI-RADS). 3rd ed. Reston, Va.: American College of Radiology, 1998.
31
Liberman L ,Menell JH . Breast Imaging Reporting and Data System (BI-RADS). Radiol Clin North Am 2002;40:409-430
CrossRef | Web of Science | Medline32
van Asperen CJ ,Tollenaar RAEM ,Krol-Warmerdam EMM , et al. Possible consequences of applying guidelines to healthy women with a family history of breast cancer. Eur J Hum Genet 2003;11:633-636
CrossRef | Web of Science | Medline33
Kuhl CK ,Schmutzler RK ,Leutner CC , et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000;215:267-279
Web of Science | Medline34
Tilanus-Linthorst MMA ,Obdeijn IMM ,Bartels KCM ,de Koning HJ ,Oudkerk M . First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 2000;63:53-60
CrossRef | Web of Science | Medline35
Stoutjesdijk MJ ,Boetes C ,Jager GJ , et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 2001;93:1095-1102
CrossRef | Web of Science | Medline36
Podo F ,Sardanelli F ,Canese R , et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 2002;21:Suppl:115-124
Web of Science | Medline37
Lalloo F ,Boggis CRM ,Evans DGR ,Shenton A ,Threlfall AG ,Howell A . Screening by mammography, women with a family history of breast cancer. Eur J Cancer 1998;34:937-940
CrossRef | Web of Science | Medline38
Kollias J ,Sibbering DM ,Blamey RW , et al. Screening women aged less than 50 years with a familial history of breast cancer. Eur J Cancer 1998;34:878-883
CrossRef | Web of Science | Medline39
Liberman L ,Morris EA ,Benton CL ,Abramson AF ,Dershaw DD . Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk women. Cancer 2003;98:377-388
CrossRef | Web of Science | Medline
- Citing Articles (365)
Citing Articles
1
Vanessa R. Blair. (2012) Familial Gastric Cancer: Genetics, Diagnosis, and Management. Surgical Oncology Clinics of North America 21:1, 35-56
CrossRef2
Ariela L. Marshall, Susan M. Domchek, Susan P. Weinstein. (2012) Follow-up Frequency and Compliance in Women with Probably Benign Findings on Breast Magnetic Resonance Imaging. Academic Radiology
CrossRef3
Sughra Raza, Meera Sekar, Eugene M.W. Ong, Robyn L. Birdwell. (2012) Small Masses on Breast MR. Academic Radiology
CrossRef4
Charlotte Curtis, Richard Frayne, Elise Fear. (2012) Semiautomated Multimodal Breast Image Registration. International Journal of Biomedical Imaging 2012, 1-14
CrossRef5
, Nina Hallowell, Brandi Baylock, Louise Heiniger, Phyllis N. Butow, Deepa Patel, Bettina Meiser, Christobel Saunders, Melanie A. Price. (2011) Looking different, feeling different: women’s reactions to risk-reducing breast and ovarian surgery. Familial Cancer
CrossRef6
Eun Sook Ko, Byung Hee Lee, Hye Young Choi, Rock Bum Kim, Woo-Chul Noh. (2011) Background enhancement in breast MR: Correlation with breast density in mammography and background echotexture in ultrasound. European Journal of Radiology 80:3, 719-723
CrossRef7
Erica Ambeba, Faina Linkov. (2011) Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer. Future Oncology 7:12, 1399-1414
CrossRef8
Luisa C. Kropcho, Shawn T. Steen, Alice P. Chung, Myung-Shin Sim, Daniel L. Kirsch, Armando E. Giuliano. (2011) Preoperative Breast MRI in the Surgical Treatment of Ductal Carcinoma In Situ. The Breast Journalno-no
CrossRef9
M. Cohen, J. Jacquemier, C. Maestro, P. Pujol, E. Saada. (2011) Femmes à risque. Oncologie
CrossRef10
M. D. Dorrius, R. M. Pijnappel, M. C. Jansen, L. Jansen, P. Kappert, M. Oudkerk, P. E. Sijens. (2011) The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging. European Radiology
CrossRef11
Seunghoon Ha, Mark J Hamamura, Werner W Roeck, James Hugg, Douglas J Wagenaar, Dirk Meier, Bradley E Patt, Orhan Nalcioglu. (2011) Feasibility study of a unilateral RF array coil for MR-scintimammography. Physics in Medicine and Biology 56:21, 6809-6822
CrossRef12
Catherine Colin, Clément Devic, Alain Noël, Muriel Rabilloud, Marie-Thérèse Zabot, Sylvie Pinet-Isaac, Sophie Giraud, Benjamin Riche, Pierre-Jean Valette, Claire Rodriguez-Lafrasse, Nicolas Foray. (2011) DNA double-strand breaks induced by mammographic screening procedures in human mammary epithelial cells. International Journal of Radiation Biology 87:11, 1103-1112
CrossRef13
Meghan L. Underhill, Suzanne S. Dickerson. (2011) Engaging in Medical Vigilance: Understanding the Personal Meaning of Breast Surveillance. Oncology Nursing Forum 38:6, 686-694
CrossRef14
Monica Morrow, Janet Waters, Elizabeth Morris. (2011) MRI for breast cancer screening, diagnosis, and treatment. The Lancet 378:9805, 1804-1811
CrossRef15
Geertruida H. De Bock, Jan Willem Hesselink, Carriene Roorda, Jaap De Vries, Harry Hollema, Jan P.C. Jaspers, Theo Kok, Paul M.N. Werker, Jan C. Oosterwijk, Marian J.E. Mourits. (2011) Model of care for women at increased risk of breast and ovarian cancer. Maturitas
CrossRef16
Zoltán Mátrai, Gusztáv Gulyás, László Tóth, Ákos Sávolt, Csaba Kunos, Pál Pesthy, Alexandra Bartal, Éva Szabó, Miklós Kásler. (2011) Emlőnagyobbító műtét után kialakult emlőrákok ellátásának speciális megfontolásai. Orvosi Hetilap 152:42, 1679-1691
CrossRef17
Belinda E. Kiely, Lucinda K. Hossack, Clair L. Shadbolt, Anna Davis, Robin Cassumbhoy, Kate Moodie, Yoland Antill, Gillian Mitchell. (2011) Practicalities of developing a breast magnetic resonance imaging screening service for women at high risk for breast cancer. ANZ Journal of Surgery 81:10, 688-693
CrossRef18
Rachel A. Freedman, Ann H. Partridge. (2011) Adjuvant therapies for very young women with early stage breast cancer. The Breast 20, S146-S149
CrossRef19
M. J. Titulaer, R. Soffietti, J. Dalmau, N. E. Gilhus, B. Giometto, F. Graus, W. Grisold, J. Honnorat, P. A. E. Sillevis Smitt, R. Tanasescu, C. A. Vedeler, R. Voltz, J. J. G. M. Verschuuren. 2011. Screening for Tumours in Paraneoplastic Syndromes. , 309-320.
CrossRef20
Carla Meeuwis, Jeroen Veltman, Hester N. Hall, Roel D. M. Mus, Carla Boetes, Jelle O. Barentsz, Ritse M. Mann. (2011) MR-guided breast biopsy at 3T: diagnostic yield of large core needle biopsy compared with vacuum-assisted biopsy. European Radiology
CrossRef21
E. Bassetti, F. Pediconi, M.L. Luciani, E. Santucci, E. Miglio, R. Candreva. (2011) Breast prosthesis: Management of patients after plastic surgery. Journal of Ultrasound 14:3, 113-121
CrossRef22
Shilpen Patel, Reshma Jagsi, Natalie Cook, Luke Hughes-Davies, Christine Parkinson. (2011) The International Core Literature Consensus (ICLC): an Alternative Curriculum for Oncologists. Journal of Cancer Education 26:3, 420-426
CrossRef23
H. Harris, I. Nippert, C. Julian-Reynier, J. Schmidtke, C. Asperen, D. Gadzicki, A. Tibben, D. G. Evans. (2011) Familial breast cancer: is it time to move from a reactive to a proactive role?. Familial Cancer 10:3, 501-503
CrossRef24
Steven A. Narod. (2011) Screening of women at high risk for breast cancer. Preventive Medicine 53:3, 127-130
CrossRef25
J. Balmana, O. Diez, I. T. Rubio, F. Cardoso, . (2011) BRCA in breast cancer: ESMO Clinical Practice Guidelines. Annals of Oncology 22:Supplement 6, vi31-vi34
CrossRef26
Federica Pediconi, Elena Miglio, Marianna Telesca, Maria Laura Luciani, Miles A. Kirchin, Roberto Passariello, Carlo Catalano. (2011) Effect of Preoperative Breast Magnetic Resonance Imaging on Surgical Decision Making and Cancer Recurrence Rates. Investigative Radiology1
CrossRef27
Sarah S. K. Tang, Gerald P. H. Gui. (2011) A Review of the Oncologic and Surgical Management of Breast Cancer in the Augmented Breast: Diagnostic, Surgical and Surveillance Challenges. Annals of Surgical Oncology 18:8, 2173-2181
CrossRef28
Huong T. Le-Petross, Mahesh K. Shetty. (2011) Magnetic Resonance Imaging and Breast Ultrasonography as an Adjunct to Mammographic Screening in High-Risk Patients. Seminars in Ultrasound, CT, and MRI 32:4, 266-272
CrossRef29
Valencia King, D David Dershaw. (2011) Combining MRI with mammography: a more effective approach to breast cancer detection. Expert Review of Anticancer Therapy 11:8, 1155-1158
CrossRef30
Sanaz A. Jansen. (2011) Ductal Carcinoma In Situ: Detection, Diagnosis, and Characterization with Magnetic Resonance Imaging. Seminars in Ultrasound, CT, and MRI 32:4, 306-318
CrossRef31
Liezel Taylor, Sarinah Basro, Justus P. Apffelstaedt, Karin Baatjes. (2011) Time for a re-evaluation of mammography in the young? Results of an audit of mammography in women younger than 40 in a resource restricted environment. Breast Cancer Research and Treatment 129:1, 99-106
CrossRef32
Wendy B. DeMartini, Brenda F. Kurland, Robert L. Gutierrez, C. Craig Blackmore, Sue Peacock, Constance D. Lehman. (2011) Probability of malignancy for lesions detected on breast MRI: a predictive model incorporating BI-RADS imaging features and patient characteristics. European Radiology 21:8, 1609-1617
CrossRef33
Debra L. Monticciolo. (2011) Magnetic Resonance Imaging of the Breast for Cancer Diagnosis and Staging. Seminars in Ultrasound, CT, and MRI 32:4, 319-330
CrossRef34
Kevin M. Kelly, Gary A. Richwald. (2011) Automated Whole-Breast Ultrasound: Advancing the Performance of Breast Cancer Screening. Seminars in Ultrasound, CT, and MRI 32:4, 273-280
CrossRef35
S. U. Dhar, H. P. Cooper, T. Wang, B. Parks, S. A. Staggs, S. Hilsenbeck, S. E. Plon. (2011) Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers. Breast Cancer Research and Treatment 129:1, 221-227
CrossRef36
Ingrid E. Fakkert, Liesbeth Jansen, Kees Meijer, Theo Kok, Jan C. Oosterwijk, Marian J. E. Mourits, Geertruida H. Bock. (2011) Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy. Breast Cancer Research and Treatment 129:1, 157-164
CrossRef37
Zsolt Nagy, Mónika Csanád, Katalin Tóth, Szabolcs Máté, József Gábor Joó. (2011) A BRCA-génmutációt hordozó nők klinikogenetikai ellátása: szűrés, diagnosztika, terápia. Orvosi Hetilap 152:23, 913-918
CrossRef38
S. C. Partridge, H. Rahbar, R. Murthy, X. Chai, B. F. Kurland, W. B. DeMartini, C. D. Lehman. (2011) Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics. Magnetic Resonance in Medicine 65:6, 1759-1767
CrossRef39
Edwin J. Yau, Robert L. Gutierrez, Wendy B. DeMartini, Peter R. Eby, Sue Peacock, Constance D. Lehman. (2011) The Utility of Breast MRI as a Problem-Solving Tool. The Breast Journal 17:3, 273-280
CrossRef40
Ayodele Ayoola, Suganthi Alagarsamy, Jerry Jaboin, Suman Rao. (2011) Increase in Mastectomies Performed in Patients in the Community Setting Undergoing MRI. The Breast Journal 17:3, 256-259
CrossRef41
Ana Cristina Vargas, Jorge S. Reis-Filho, Sunil R. Lakhani. (2011) Phenotype-Genotype Correlation in Familial Breast Cancer. Journal of Mammary Gland Biology and Neoplasia 16:1, 27-40
CrossRef42
Amy S. Clark, Susan M. Domchek. (2011) Clinical Management of Hereditary Breast Cancer Syndromes. Journal of Mammary Gland Biology and Neoplasia 16:1, 17-25
CrossRef43
Minkyo Song, Kyoung-Mu Lee, Daehee Kang. (2011) Breast cancer prevention based on gene-environment interaction. Molecular Carcinogenesis 50:4, 280-290
CrossRef44
Dror Lederman, Bin Zheng, Xingwei Wang, Xiao Hui Wang, David Gur. (2011) Improving Breast Cancer Risk Stratification Using Resonance-Frequency Electrical Impedance Spectroscopy Through Fusion of Multiple Classifiers. Annals of Biomedical Engineering 39:3, 931-945
CrossRef45
Rosalind Candelaria, Bruno D. Fornage. (2011) Second-look us examination of MR-detected breast lesions. Journal of Clinical Ultrasound 39:3, 115-121
CrossRef46
C. Boetes. (2011) Update on Screening Breast MRI in High-Risk Women. Obstetrics and Gynecology Clinics of North America 38:1, 149-158
CrossRef47
Stephen Feig. (2011) Comparison of Costs and Benefits of Breast Cancer Screening with Mammography, Ultrasonography, and MRI. Obstetrics and Gynecology Clinics of North America 38:1, 179-196
CrossRef48
Katherine L. Nathanson, Susan M. Domchek. (2011) Therapeutic Approaches for Women Predisposed to Breast Cancer. Annual Review of Medicine 62:1, 295-306
CrossRef49
Elrasheid A. H. Kheirelseid, Hanzali Jumustafa, Nicola Miller, Catherine Curran, Karl Sweeney, Carmel Malone, Ray McLaughlin, John Newell, Michael J. Kerin. (2011) Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. Breast Cancer Research and Treatment 126:1, 131-140
CrossRef50
Victor R. Grann, Priya R. Patel, Judith S. Jacobson, Ellen Warner, Daniel F. Heitjan, Maxine Ashby-Thompson, Dawn L. Hershman, Alfred I. Neugut. (2011) Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Research and Treatment 125:3, 837-847
CrossRef51
Francesco Sardanelli, Franca Podo, Filippo Santoro, Siranoush Manoukian, Silvana Bergonzi, Giovanna Trecate, Daniele Vergnaghi, Massimo Federico, Laura Cortesi, Stefano Corcione, Sandro Morassut, Cosimo Di Maggio, Anna Cilotti, Laura Martincich, Massimo Calabrese, Chiara Zuiani, Lorenzo Preda, Bernardo Bonanni, Luca A. Carbonaro, Alma Contegiacomo, Pietro Panizza, Ernesto Di Cesare, Antonella Savarese, Marcello Crecco, Daniela Turchetti, Maura Tonutti, Paolo Belli, Alessandro Del Maschio. (2011) Multicenter Surveillance of Women at High Genetic Breast Cancer Risk Using Mammography, Ultrasonography, and Contrast-Enhanced Magnetic Resonance Imaging (the High Breast Cancer Risk Italian 1 Study). Investigative Radiology 46:2, 94-105
CrossRef52
Daphne Tsoi, Claire Holloway, Louise Bordeleau, Christine Brezden-Masley, Petrina Causer, Ellen Warner. (2011) Willingness of breast cancer survivors to participate in a randomized controlled trial of digital mammography with or without MRI as breast cancer surveillance: A feasibility study. The Breast 20:1, 96-98
CrossRef53
Bin Zheng, Dror Lederman, Jules H. Sumkin, Margarita L. Zuley, Michelle Z. Gruss, Linda S. Lovy, David Gur. (2011) A Preliminary Evaluation of Multi-probe Resonance-frequency Electrical Impedance Based Measurements of the Breast. Academic Radiology 18:2, 220-229
CrossRef54
J. Camps Herrero. (2011) Breast Magnetic Resonance Imaging: State of the art and clinical applications. Radiología (English Edition) 53:1, 27-38
CrossRef55
Hyun-chong Cho, Lubomir Hadjiiski, Berkman Sahiner, Heang-Ping Chan, Mark Helvie, Chintana Paramagul, Alexis V. Nees. (2011) Similarity evaluation in a content-based image retrieval (CBIR) CADx system for characterization of breast masses on ultrasound images. Medical Physics 38:4, 1820
CrossRef56
E. Warner. (2011) Impact of MRI surveillance and breast cancer detection in young women with BRCA mutations. Annals of Oncology 22:Supplement 1, i44-i49
CrossRef57
Kathryn P. Lowry, Janie M. Lee, Chung Y. Kong, Pamela M. McMahon, Michael E. Gilmore, Jessica E. Cott Chubiz, Etta D. Pisano, Constantine Gatsonis, Paula D. Ryan, Elissa M. Ozanne, G. Scott Gazelle. (2011) Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers. Cancern/a-n/a
CrossRef58
Hidetake Yabuuchi, Yoshio Matsuo, Shunya Sunami, Takeshi Kamitani, Satoshi Kawanami, Taro Setoguchi, Shuji Sakai, Masamitsu Hatakenaka, Makoto Kubo, Eriko Tokunaga, Hidetaka Yamamoto, Hiroshi Honda. (2011) Detection of non-palpable breast cancer in asymptomatic women by using unenhanced diffusion-weighted and T2-weighted MR imaging: comparison with mammography and dynamic contrast-enhanced MR imaging. European Radiology 21:1, 11-17
CrossRef59
Kathy Schilling, Deepa Narayanan, Judith E. Kalinyak, Juliette The, Maria Victoria Velasquez, Simone Kahn, Matthew Saady, Ravinder Mahal, Larraine Chrystal. (2011) Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging. European Journal of Nuclear Medicine and Molecular Imaging 38:1, 23-36
CrossRef60
Maxine S. Jochelson, Elizabeth A. Morris. (2011) An Imaging Approach to High-Risk Screening for Breast Cancer. Seminars in Roentgenology 46:1, 68-75
CrossRef61
Ellen Warner, Petrina A. Causer, John W-N. Wong, Frances C. Wright, Roberta A. Jong, Kimberley A. Hill, Sandra J. Messner, Martin J. Yaffe, Steven A. Narod, Donald B. Plewes. (2011) Improvement in DCIS Detection Rates by MRI Over Time in a High-Risk Breast Screening Study. The Breast Journal 17:1, 9-17
CrossRef62
S.E. Harms. (2011) Breast MRI Screening of Women With a Personal History of Breast Cancer. Breast Diseases: A Year Book Quarterly 22:2, 140-141
CrossRef63
Annemiek Visser, Judith B Prins, Nicoline Hoogerbrugge, Hanneke WM van Laarhoven. (2011) Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial. BMC Women's Health 11:1, 39
CrossRef64
Randal L. Croshaw, Megan L. Marshall, Tesha L. Williams, Kathleen M. Erb, Thomas B. Julian. (2011) Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers. International Journal of Breast Cancer 2011, 1-9
CrossRef65
M. J. Titulaer, R. Soffietti, J. Dalmau, N. E. Gilhus, B. Giometto, F. Graus, W. Grisold, J. Honnorat, P. A. E. Sillevis Smitt, R. Tanasescu, C. A. Vedeler, R. Voltz, J. J. G. M. Verschuuren. (2011) Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force. European Journal of Neurology 18:1, 19-e3
CrossRef66
K. P. Siziopikou, P. Jokich, M. Cobleigh. (2011) Pathologic Findings in MRI-Guided Needle Core Biopsies of the Breast in Patients with Newly Diagnosed Breast Cancer. International Journal of Breast Cancer 2011, 1-3
CrossRef67
Dror Lederman, Bin Zheng, Xingwei Wang, Jules H. Sumkin, David Gur. (2011) A GMM-based breast cancer risk stratification using a resonance-frequency electrical impedance spectroscopy. Medical Physics 38:3, 1649
CrossRef68
Chiara Perono Biacchiardi, Davide Brizzi, Franco Genta, Eugenio Zanon, Marco Camanni, Francesco Deltetto. (2011) Breast Cancer Preoperative Staging: Does Contrast-Enhanced Magnetic Resonance Mammography Modify Surgery?. International Journal of Breast Cancer 2011, 1-10
CrossRef69
Thomas J. Painter, Peter J. DiPasco, Subhasis Misra, Eli Avisar. (2011) Effect of Magnetic Resonance Imaging on Breast Conservation Therapy versus Mastectomy: A Review of the Literature. International Journal of Surgical Oncology 2011, 1-6
CrossRef70
P. Huthwaite, F. Simonetti. (2011) High-resolution imaging without iteration: a fast and robust method for breast ultrasound tomography. The Journal of the Acoustical Society of America 130:3, 1721
CrossRef71
Liane E. Philpotts. (2011) Comprehensive Breast Imaging 2010. Seminars in Roentgenology 46:1, 7-17
CrossRef72
J. Camps Herrero. (2011) Resonancia magnética de mama: estado actual y aplicación clínica. Radiología 53:1, 27-38
CrossRef73
Huong T. Le-Petross, Gary J. Whitman, Deanne P. Atchley, Ying Yuan, Angelica Gutierrez-Barrera, Gabriel N. Hortobagyi, Jennifer K. Litton, Banu K. Arun. (2011) Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer. Cancern/a-n/a
CrossRef74
Marc D. Schwartz, Claudine Isaacs, Kristi D. Graves, Elizabeth Poggi, Beth N. Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L. Taylor, Lauren Perley. (2011) Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance. Cancern/a-n/a
CrossRef75
Patricia K. Ravert, Crystal Huffaker. (2010) Breast cancer screening in women: An integrative literature review. Journal of the American Academy of Nurse Practitioners 22:12, 668-673
CrossRef76
(2010) Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. The Lancet Oncology 11:12, 1127-1134
CrossRef77
Steven A. Narod. (2010) BRCA mutations in the management of breast cancer: the state of the art. Nature Reviews Clinical Oncology 7:12, 702-707
CrossRef78
Mary S. Newell, Robyn L. Birdwell, Carl J. D'Orsi, Lawrence W. Bassett, Mary C. Mahoney, Lisa Bailey, Wendie A. Berg, Jennifer A. Harvey, Cheryl R. Herman, Stuart S. Kaplan, Laura Liberman, Ellen B. Mendelson, Jay R. Parikh, Rachel Rabinovitch, Eric L. Rosen, M. Linda Sutherland. (2010) ACR Appropriateness Criteria® on Nonpalpable Mammographic Findings (Excluding Calcifications). Journal of the American College of Radiology 7:12, 920-930
CrossRef79
Karen L. Belkić, Miri Cohen, Marcela Márquez, Miriam Mints, Brigitte Wilczek, Anne H. Berman, Enrique Castellanos, Martha Castellanos. (2010) Screening of high-risk groups for breast and ovarian cancer in Europe: a focus on the Jewish population. Oncology Reviews 4:4, 233-267
CrossRef80
Shou-Jen Kuo, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Dar-Ren Chen, Li-Sheng Chen. (2010) Optimal two-stage breast cancer screening for countries with intermediate or low incidence of breast cancer. Journal of Evaluation in Clinical Practice 16:6, 1345-1352
CrossRef81
Jennifer L. Griffin, Mark D. Pearlman. (2010) Breast Cancer Screening in Women at Average Risk and High Risk. Obstetrics & Gynecology 116:6, 1410-1421
CrossRef82
S. Pruthi, B. S. Gostout, N. M. Lindor. (2010) Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer. Mayo Clinic Proceedings 85:12, 1111-1120
CrossRef83
Kevin M. Kelly, Judy Dean, Sung-Jae Lee, W. Scott Comulada. (2010) Breast cancer detection: radiologists’ performance using mammography with and without automated whole-breast ultrasound. European Radiology 20:11, 2557-2564
CrossRef84
Marijke C. Jansen-van der Weide, Marcel J. W. Greuter, Liesbeth Jansen, Jan C. Oosterwijk, Ruud M. Pijnappel, Geertruida H. Bock. (2010) Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis. European Radiology 20:11, 2547-2556
CrossRef85
Wendy B. DeMartini, Laura Ichikawa, Bonnie C. Yankaskas, Diana Buist, Karla Kerlikowske, Berta Geller, Tracy Onega, Robert D. Rosenberg, Constance D. Lehman. (2010) Breast MRI in Community Practice: Equipment and Imaging Techniques at Facilities in the Breast Cancer Surveillance Consortium. Journal of the American College of Radiology 7:11, 878-884
CrossRef86
C.C. Riedl, L. Ponhold, R. Gruber, K. Pinker, T.H. Helbich. (2010) Neues zum Hochrisikomammascreening. Der Radiologe 50:11, 955-963
CrossRef87
C. D. Lehman. (2010) Magnetic Resonance Imaging in the Evaluation of Ductal Carcinoma In Situ. JNCI Monographs 2010:41, 150-151
CrossRef88
Deborah Hemel, Susan M. Domchek. (2010) Breast Cancer Predisposition Syndromes. Hematology/Oncology Clinics of North America 24:5, 799-814
CrossRef89
Dominic Varga, Jochem Koenig, Kathrin Kuhr, Kathrin Strunz, Verena Geyer, Christian Kurzeder, Ziad Atassi, Maria Blettner, Rolf Kreienberg, Achim Woeckel. (2010) Comparison of early onset breast cancer patients to older premenopausal breast cancer patients. Archives of Gynecology and Obstetrics 282:4, 427-432
CrossRef90
Leisha Elmore, Julie A. Margenthaler. (2010) Use of Breast MRI Surveillance in Women at High Risk for Breast Cancer: A Single-Institutional Experience. Annals of Surgical Oncology 17:S3, 263-267
CrossRef91
Edward A. Sickles. (2010) The Use of Breast Imaging to Screen Women at High Risk for Cancer. Radiologic Clinics of North America 48:5, 859-878
CrossRef92
Leisha Elmore, Julie A. Margenthaler. (2010) Breast MRI Surveillance in Women with Prior Curative-Intent Therapy for Breast Cancer. Journal of Surgical Research 163:1, 58-62
CrossRef93
Stephen Feig. (2010) Cost-Effectiveness of Mammography, MRI, and Ultrasonography for Breast Cancer Screening. Radiologic Clinics of North America 48:5, 879-891
CrossRef94
Mahesh K. Shetty. (2010) Screening for Breast Cancer with Mammography: Current Status and An Overview. Indian Journal of Surgical Oncology 1:3, 218-223
CrossRef95
Susan Weinstein, Mark Rosen. (2010) Breast MR Imaging: Current Indications and Advanced Imaging Techniques. Radiologic Clinics of North America 48:5, 1013-1042
CrossRef96
Einat Even-Sapir, Moshe Inbar. (2010) PET in women with high risk for breast or ovarian cancer. The Lancet Oncology 11:9, 899-905
CrossRef97
Basak E. Dogan, Wei Tse Yang. (2010) Why Is Breast MRI so Controversial?. Current Breast Cancer Reports 2:3, 159-165
CrossRef98
Judit Sanz, Teresa Ramón y Cajal, Asunción Torres, Esther Darder, Neus Gadea, Angela Velasco, Daniel Fortuny, Consol López, David Fisas, Joan Brunet, M. Carmen Alonso, Judith Balmaña. (2010) Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain. Familial Cancer 9:3, 297-304
CrossRef99
Thomas A. Weber. (2010) Simple methods for evaluating and comparing binary experiments. Theory and Decision 69:2, 257-288
CrossRef100
Marc A Bollet, Youlia M Kirova, Alain Fourquet, Patricia de Cremoux, Fabien Reyal. (2010) Prognostic factors for local recurrence following breast-conserving treatment in young women. Expert Review of Anticancer Therapy 10:8, 1215-1227
CrossRef101
Ava Kwong, Connie H. N. Wong, Catherine Shea, Dacita T. K. Suen, Catherine L. Y. Choi. (2010) Choice of Management of Southern Chinese BRCA Mutation Carriers. World Journal of Surgery 34:7, 1416-1426
CrossRef102
Steven A Narod. (2010) Screening of women at high familial risk of breast cancer. Women's Health 6:4, 509-510
CrossRef103
C. Malhaire, C. Khoury, F. Thibault, A. Athanasiou, P. Petrow, L. Ollivier, A. Tardivon. (2010) Vacuum-assisted biopsies under MR guidance: results of 72 procedures. European Radiology 20:7, 1554-1562
CrossRef104
Rebecca Rakow-Penner, Bruce Daniel, Gary H. Glover. (2010) Detecting blood oxygen level-dependent (BOLD) contrast in the breast. Journal of Magnetic Resonance Imaging 32:1, 120-129
CrossRef105
Monica Morrow. (2010) Magnetic Resonance Imaging for Screening, Diagnosis, and Eligibility for Breast-conserving Surgery: Promises and Pitfalls. Surgical Oncology Clinics of North America 19:3, 475-492
CrossRef106
L. Apesteguía Ciriza. (2010) Manejo de pacientes de alto riesgo de cáncer de mama. Radiología 52, 18-21
CrossRef107
Paige Teller, Valerie J. Jefford, Sheryl G. A. Gabram, Mary Newell, Grant W. Carlson. (2010) The Utility of Breast MRI in the Management of Breast Cancer. The Breast Journalno-no
CrossRef108
Hao Peng, Craig S Levin. (2010) Design study of a high-resolution breast-dedicated PET system built from cadmium zinc telluride detectors. Physics in Medicine and Biology 55:9, 2761-2788
CrossRef109
Francesco Sardanelli, Carla Boetes, Bettina Borisch, Thomas Decker, Massimo Federico, Fiona J. Gilbert, Thomas Helbich, Sylvia H. Heywang-Köbrunner, Werner A. Kaiser, Michael J. Kerin, Robert E. Mansel, Lorenza Marotti, Laura Martincich, Louis Mauriac, Hanne Meijers-Heijboer, Roberto Orecchia, Pietro Panizza, Antonio Ponti, Arnie D. Purushotham, Peter Regitnig, Marco Rosselli Del Turco, Fabienne Thibault, Robin Wilson. (2010) Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group. European Journal of Cancer 46:8, 1296-1316
CrossRef110
Gillian M. Newstead. (2010) MR Imaging of Ductal Carcinoma In Situ. Magnetic Resonance Imaging Clinics of North America 18:2, 225-240
CrossRef111
Ian C. Bennett, Jennifer Muller, Linda Cockburn, Helen Joshua, Gillian Thorley, Christine Baker, Nili Wood, Jane Brazier, Mark Jones, Nathan Dunn, Michael Gattas. (2010) Outcomes of Multimodality Breast Screening for Women at Increased Risk of Familial Breast Cancer. World Journal of Surgery 34:5, 979-986
CrossRef112
Icro Meattini, Lorenzo Livi, Calogero Saieva, Livia Marrazzo, Andrea Rampini, Carmine Iermano, Maria Grazia Papi, Beatrice Detti, Silvia Scoccianti, Giampaolo Biti. (2010) Breast Cancer Following Hodgkin’s Disease: The Experience of the University of Florence. The Breast Journal 16:3, 290-296
CrossRef113
Peter R. Eby, Wendy B. DeMartini, Robert L. Gutierrez, Constance D. Lehman. (2010) Probably Benign Lesions Detected on Breast MR Imaging. Magnetic Resonance Imaging Clinics of North America 18:2, 309-321
CrossRef114
C. Boetes. (2010) Update on Screening Breast MRI in High-Risk Women. Magnetic Resonance Imaging Clinics of North America 18:2, 241-247
CrossRef115
J. Balmana, O. Diez, I. Rubio, M. Castiglione, . (2010) BRCA in breast cancer: ESMO Clinical Practice Guidelines. Annals of Oncology 21:Supplement 5, v20-v22
CrossRef116
Nancie Petrucelli, Mary B. Daly, Gerald L. Feldman. (2010) Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. Genetics in Medicine 12:5, 245-259
CrossRef117
Dustin Newell, Ke Nie, Jeon-Hor Chen, Chieh-Chih Hsu, Hon J. Yu, Orhan Nalcioglu, Min-Ying Su. (2010) Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement. European Radiology 20:4, 771-781
CrossRef118
Christopher R. Loiselle, Peter R. Eby, Wendy B. DeMartini, Sue Peacock, Nathan Bittner, Constance D. Lehman, Janice N. Kim. (2010) Dynamic Contrast-Enhanced MRI Kinetics of Invasive Breast Cancer: A Potential Prognostic Marker for Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 76:5, 1314-1319
CrossRef119
Joseph A. Sparano, Etta D. Pisano, Julia R. White, Kelly K. Hunt, Eleftherios P. Mamounas, Edith A. Perez, Gabriel N. Hortobagyi, Julie R. Gralow, Robert L. Comis. (2010) Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy. Breast Cancer Research and Treatment 120:2, 273-284
CrossRef120
Elisabeth Chéreau, Catherine Uzan, Corinne Balleyguier, Julie Chevalier, Brigitte Bressac de Paillerets, Olivier Caron, Françoise Rimareix, Marie-Christine Mathieu, Martin Koskas, Céline Bourgier, Fabrice André, Clarisse Dromain, Suzette Delaloge. (2010) Characteristics, Treatment, and Outcome of Breast Cancers Diagnosed in <i>BRCA1</i> and <i>BRCA2</i> Gene Mutation Carriers in Intensive Screening Programs Including Magnetic Resonance Imaging. Clinical Breast Cancer 10:2, 113-118
CrossRef121
Kwan-Hoong Ng, Oliver Faust, Rajendra Acharya U. (2010) Health Effects and Safety of Magnetic Resonance Imaging. Journal of Medical Systems
CrossRef122
Kevin M. Kelly, Judy Dean, W. Scott Comulada, Sung-Jae Lee. (2010) Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. European Radiology 20:3, 734-742
CrossRef123
Savannah C. Partridge, Wendy B. DeMartini, Brenda F. Kurland, Peter R. Eby, Steven W. White, Constance D. Lehman. (2010) Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. Journal of Magnetic Resonance Imaging 31:3, 562-570
CrossRef124
Johnny Ray Bernard, Laura A. Vallow, Elizabeth R. DePeri, Rebecca B. McNeil, Deborah G. Feigel, Surabhi Amar, Steven J. Buskirk, Edith A. Perez. (2010) In Newly Diagnosed Breast Cancer, Screening MRI of the Contralateral Breast Detects Mammographically Occult Cancer, Even in Elderly Women: The Mayo Clinic in Florida Experience. The Breast Journal 16:2, 118-126
CrossRef125
Ting Wang, Kan Wang, Qing Yao, Jiang-hao Chen, Rui Ling, Ju-liang Zhang, Xiu-zhen Dong, Feng Fu, Ke-feng Dou, Ling Wang. (2010) Prospective Study on Combination of Electrical Impedance Scanning and Ultrasound in Estimating Risk of Development of Breast Cancer in Young Women. Cancer Investigation 28:3, 295-303
CrossRef126
Elizabeth A. Morris. (2010) Diagnostic Breast MR Imaging: Current Status and Future Directions. Magnetic Resonance Imaging Clinics of North America 18:1, 57-74
CrossRef127
Aurelie D. Laidevant, Serghei Malkov, Chris I. Flowers, Karla Kerlikowske, John A. Shepherd. (2010) Compositional breast imaging using a dual-energy mammography protocol. Medical Physics 37:1, 164
CrossRef128
Carol H. Lee, D. David Dershaw, Daniel Kopans, Phil Evans, Barbara Monsees, Debra Monticciolo, R. James Brenner, Lawrence Bassett, Wendie Berg, Stephen Feig, Edward Hendrick, Ellen Mendelson, Carl D'Orsi, Edward Sickles, Linda Warren Burhenne. (2010) Breast Cancer Screening With Imaging: Recommendations From the Society of Breast Imaging and the ACR on the Use of Mammography, Breast MRI, Breast Ultrasound, and Other Technologies for the Detection of Clinically Occult Breast Cancer. Journal of the American College of Radiology 7:1, 18-27
CrossRef129
Inge-Marie A. Obdeijn, Claudette E. Loo, Adriana J. Rijnsburger, Martin N. J. M. Wasser, Elisabeth Bergers, Theo Kok, Jan G. M. Klijn, Carla Boetes. (2010) Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition. Breast Cancer Research and Treatment 119:2, 399-407
CrossRef130
Subhadra Srinivasan, Colin M. Carpenter, Hamid R. Ghadyani, Senate J. Taka, Peter A. Kaufman, Roberta M. DiFlorio-Alexander, Wendy A. Wells, Brian W. Pogue, Keith D. Paulsen. (2010) Image guided near-infrared spectroscopy of breast tissue in vivo using boundary element method. Journal of Biomedical Optics 15:6, 061703
CrossRef131
P. Shah, M. Rosen, J. Stopfer, J. Siegfried, R. Kaltman, B. Mason, K. Armstrong, K. L. Nathanson, M. Schnall, S. M. Domchek. (2009) Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence. Breast Cancer Research and Treatment 118:3, 539-546
CrossRef132
(2009) References. Journal of the ICRU 9:2, 89-104
CrossRef133
Debra Morgan, Heather Sylvester, F. Lee Lucas, Susan Miesfeldt. (2009) Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting. Familial Cancer 8:4, 277-287
CrossRef134
Brooke E. Salzman, Kathleen Lamb, Robert F. Olszewski, Amber Tully, James Studdiford. (2009) Diagnosing Cancer in the Symptomatic Patient. Primary Care: Clinics in Office Practice 36:4, 651-670
CrossRef135
T. Arazi-Kleinman, P.A. Causer, R.A. Jong, K. Hill, E. Warner. (2009) Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
. Clinical Radiology 64:12, 1166-1174
CrossRef136
Misung Han, Philip J. Beatty, Bruce L. Daniel, Brian A. Hargreaves. (2009) Independent slab-phase modulation combined with parallel imaging in bilateral breast MRI. Magnetic Resonance in Medicine 62:5, 1221-1231
CrossRef137
Jesse C. Selber, Jonas A. Nelson, Adedayo O. Ashana, Meredith R. Bergey, Mirar N. Bristol, Seema S. Sonnad, Joseph M. Serletti, Liza C. Wu. (2009) Breast Cancer Screening Prior to Cosmetic Breast Surgery: ASPS Members’ Adherence to American Cancer Society Guidelines. Plastic and Reconstructive Surgery 124:5, 1375-1385
CrossRef138
Sylvia H. Heywang-Köbrunner, Ruchi Sinnatamby, Annette Lebeau, Antje Lebrecht, Peter D. Britton, Ingrid Schreer. (2009) Interdisciplinary consensus on the uses and technique of MR-guided vacuum-assisted breast biopsy (VAB): Results of a European consensus meeting. European Journal of Radiology 72:2, 289-294
CrossRef139
Zhijian Cao. (2009) Mammographic features of breast cancer: Analysis of 118 cases. The Chinese-German Journal of Clinical Oncology 8:11, 659-664
CrossRef140
(2009) Surveillance après traitement de cancer du sein (hors mutation). Oncologie 11:11, 589-610
CrossRef141
Janie M. Lee, Elkan F. Halpern, Elizabeth A. Rafferty, G. Scott Gazelle. (2009) Evaluating the Correlation between Film Mammography and MRI for Screening Women with Increased Breast Cancer Risk. Academic Radiology 16:11, 1323-1328
CrossRef142
M. Thill, C. Dittmer, B. Ruhland, K. Diedrich, D. Fischer. (2009) Früherkennung des Mammakarzinoms. Der Gynäkologe 42:11, 833-840
CrossRef143
Cecelia A. Bellcross, Amy A. Lemke, Laura S. Pape, Angela L. Tess, Lorraine T. Meisner. (2009) Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population. Genetics in Medicine 11:11, 783-789
CrossRef144
L.J. Hamilton, A.J. Evans, E.J. Cornford, E.A. Rakha, I.O. Ellis, W.D. Foulkes. (2009) Will MRI screening deliver the expected survival advantage in BRCA 1 carriers?. Clinical Radiology 64:11, 1045-1047
CrossRef145
Lee G. Wilke, Gloria Broadwater, Sarah Rabiner, Elizabeth Owens, Sora Yoon, Sujata Ghate, Victoria Scott, Ruth Walsh, Jay Baker, Mary Scott Soo, Catherine Ibarra-Drendall, April Stouder, Stephanie Robertson, Abbey Barron, Victoria Seewaldt. (2009) Breast self-examination: defining a cohort still in need. The American Journal of Surgery 198:4, 575-579
CrossRef146
Srila Samphao, Amanda J. Wheeler, Elizabeth Rafferty, James S. Michaelson, Michelle C. Specht, Michele A. Gadd, Kevin S. Hughes, Barbara L. Smith. (2009) Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging. The American Journal of Surgery 198:4, 538-543
CrossRef147
Dai Komata, Tetsuro Yahata, Shoji Kodama, Yu Koyama, Nobuo Takeda, Kenzo Tajima, Haruhiko Makino, Nobuaki Sato, Ichiro Muto, Katsuyoshi Hatakeyama, Kenichi Tanaka. (2009) The prevalence of hereditary breast/ovarian cancer risk in patients with a history of breast or ovarian cancer in Japanese subjects. Journal of Obstetrics and Gynaecology Research 35:5, 912-917
CrossRef148
Dorota Nowakowska. (2009) Genetic Counselling in Oncology the Role of Molecular Tests in Oncology. Polish Journal of Surgery 81:10, 491-495
CrossRef149
Sheryl G.A. Gabram, Teri Dougherty, Kathy S. Albain, Kimberly Klein, Patricia Mumby, Kit Lee, Kathy Yao, Bhuma Krishnamachari, Catheryn J. Salibay, Mary Jo Lund. (2009) Assessing Breast Cancer Risk and Providing Treatment Recommendations: Immediate Impact of an Educational Session. The Breast Journal 15, S39-S45
CrossRef150
Jeffrey A. Tice, Karla Kerlikowske. (2009) Screening and Prevention of Breast Cancer in Primary Care. Primary Care: Clinics in Office Practice 36:3, 533-558
CrossRef151
S J Howell, C Searle, V Goode, T Gardener, K Linton, R A Cowan, M A Harris, P Hopwood, R Swindell, A Norman, J Kennedy, A Howell, A M Wardley, J A Radford. (2009) The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage. British Journal of Cancer 101:4, 582-588
CrossRef152
William R. Hendee, Anthony B. Wolbarst. 2009. Biomedical Imaging Technologies. .
CrossRef153
A. W. Kurian, L. A. McClure, E. M. John, P. L. Horn-Ross, J. M. Ford, C. A. Clarke. (2009) Second Primary Breast Cancer Occurrence According to Hormone Receptor Status. JNCI Journal of the National Cancer Institute 101:15, 1058-1065
CrossRef154
Richard J. Bleicher, Robin M. Ciocca, Brian L. Egleston, Linda Sesa, Kathryn Evers, Elin R. Sigurdson, Monica Morrow. (2009) Association of Routine Pretreatment Magnetic Resonance Imaging with Time to Surgery, Mastectomy Rate, and Margin Status. Journal of the American College of Surgeons 209:2, 180-187
CrossRef155
Anders Lönneborg, Jørgen Aarøe, Vanessa Dumeaux, Anne-Lise Børresen-Dale. (2009) Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer. Expert Review of Anticancer Therapy 9:8, 1115-1123
CrossRef156
Tirtza N. Spiegel, Kimberley A. Hill, Ellen Warner. (2009) The Attitudes of Women with BRCA1 and BRCA2 Mutations toward Clinical Breast Examinations and Breast Self-Examinations. Journal of Women's Health 18:7, 1019-1024
CrossRef157
Noor M. Alnaimy, Nuha Khoumais. (2009) Role of Ultrasonography in Breast Cancer Imaging. PET Clinics 4:3, 227-240
CrossRef158
Susan Weinstein. (2009) Evolving Role of MRI in Breast Cancer Imaging. PET Clinics 4:3, 241-253
CrossRef159
Cathleen M. Waters, Abigail C. Hoover, Lindsey C. McClain, Tara T. Moore, Candice T. Rogers, Kathy Thornton. (2009) Current Guidelines and Best Practice Evidence for Intensified/Enhanced Breast Cancer Screening in Women with BRCA Mutations. The Journal for Nurse Practitioners 5:6, 447-453
CrossRef160
Suzanne M. O’Neill, Wendy S. Rubinstein, Stephen F. Sener, Scott M. Weissman, Anna C. Newlin, Daniel K. West, David B. Ecanow, Alfred W. Rademaker, Robert R. Edelman. (2009) Psychological impact of recall in high-risk breast MRI screening. Breast Cancer Research and Treatment 115:2, 365-371
CrossRef161
J. Balmana, O. Diez, M. Castiglione, . (2009) BRCA in breast cancer: ESMO Clinical Recommendations. Annals of Oncology 20:Supplement 4, iv19-iv20
CrossRef162
Joanna M. Y. Tan, E. Y. K. Ng, Rajendra Acharya U., Louis G. Keith, Jim Holmes. (2009) Comparative Study on the Use of Analytical Software to Identify the Different Stages of Breast Cancer Using Discrete Temperature Data. Journal of Medical Systems 33:2, 141-153
CrossRef163
(2009) Hereditary Breast and Ovarian Cancer Syndrome. Gynecologic Oncology 113:1, 6-11
CrossRef164
Larissa Nekhlyudov, Keith Kiarsis, Joann G. Elmore. (2009) MRI of the Breast: Does the Internet Accurately Report its Beneficial Uses and Limitations?. The Breast Journal 15:2, 189-193
CrossRef165
Charu Taneja, John Edelsberg, Derek Weycker, Amy Guo, Gerry Oster, Jeffrey Weinreb. (2009) Cost Effectiveness of Breast Cancer Screening With Contrast-Enhanced MRI in High-Risk Women. Journal of the American College of Radiology 6:3, 171-179
CrossRef166
Dževad Belkić, Karen Belkić. (2009) The general concept of signal–noise separation (SNS): mathematical aspects and implementation in magnetic resonance spectroscopy. Journal of Mathematical Chemistry 45:3, 563-597
CrossRef167
J Price, SW Chen. (2009) Screening for breast cancer with MRI: recent experience from the Australian Capital Territory. Journal of Medical Imaging and Radiation Oncology 53:1, 69-80
CrossRef168
K.D. Kurz, D. Steinhaus, V. Klar, M. Cohnen, H.J. Wittsack, A. Saleh, U. Mödder, D. Blondin. (2009) Assessment of three different software systems in the evaluation of dynamic MRI of the breast. European Journal of Radiology 69:2, 300-307
CrossRef169
Melissa C. Hulvat, Nora M. Hansen, Jacqueline S. Jeruss. (2009) Multidisciplinary Care for Patients with Breast Cancer. Surgical Clinics of North America 89:1, 133-176
CrossRef170
Martin O. Leach. (2009) Breast cancer screening in women at high risk using MRI. NMR in Biomedicine 22:1, 17-27
CrossRef171
Jiani Hu, Wenzheng Feng, Jia Hua, Quan Jiang, Yang Xuan, Tao Li, E. Mark Haacke. (2009) A high spatial resolution in vivo 1H magnetic resonance spectroscopic imaging technique for the human breast at 3 T. Medical Physics 36:11, 4870
CrossRef172
Gladys G. Lo, Victor Ai, John K.F. Chan, K.W. Li, Polly S.Y. Cheung, T.T. Wong, Micheal Ma, Raymond Lee, Daisy Chien. (2009) Diffusion-Weighted Magnetic Resonance Imaging of Breast Lesions. Journal of Computer Assisted Tomography 33:1, 63-69
CrossRef173
Michael S. Sabel. 2009. Principles of Breast Cancer Screening. , 19-40.
CrossRef174
Christopher E. Comstock. (2009) The Future of Breast Imaging. Breast Diseases: A Year Book Quarterly 20:2, 123-125
CrossRef175
Adam B. Nover, Shami Jagtap, Waqas Anjum, Hakki Yegingil, Wan Y. Shih, Wei-Heng Shih, Ari D. Brooks. (2009) Modern Breast Cancer Detection: A Technological Review. International Journal of Biomedical Imaging 2009, 1-14
CrossRef176
Matthew P. Larocque, Alasdair Syme, Atiyah Yahya, Keith Wachowicz, Joan Allalunis-Turner, B. Gino Fallone. (2009) Temporal and dose dependence of T2 and ADC at 9.4 T in a mouse model following single fraction radiation therapy. Medical Physics 36:7, 2948
CrossRef177
2009. BIBLIOGRAPHIE. , 176-189.
CrossRef178
Ellen M. Van Cann, Mark Rijpkema, Arend Heerschap, Andries van der Bilt, Ron Koole, Paul J.W. Stoelinga. (2008) Quantitative dynamic contrast-enhanced MRI for the assessment of mandibular invasion by squamous cell carcinoma. Oral Oncology 44:12, 1147-1154
CrossRef179
Jennifer Zakhireh, Rachel Gomez, Laura Esserman. (2008) Converting evidence to practice: A guide for the clinical application of MRI for the screening and management of breast cancer. European Journal of Cancer 44:18, 2742-2752
CrossRef180
Elon J. Granader, Ben Dwamena, Ruth C. Carlos. (2008) MRI and Mammography Surveillance of Women at Increased Risk for Breast Cancer. Academic Radiology 15:12, 1590-1595
CrossRef181
Patricia R. Geraghty, Maurice A.A.J. van den Bosch, Daniel M. Spielman, Sandeep Hunjan, Robyn L. Birdwell, Katherine J. Fong, Lara A. Stables, Marowan Zakhour, Robert J. Herfkens, Debra M. Ikeda. (2008) MRI and 1 H MRS of The Breast: Presence of a Choline Peak as Malignancy Marker is Related to k21 Value of the Tumor in Patients with Invasive Ductal Carcinoma. The Breast Journal 14:6, 574-580
CrossRef182
A. Peters, J.G. Chase, E.E.W. Van Houten. (2008) Digital Image Elasto-Tomography: Combinatorial and Hybrid Optimization Algorithms for Shape-Based Elastic Property Reconstruction. IEEE Transactions on Biomedical Engineering 55:11, 2575-2583
CrossRef183
Regina Kroiss, V. Winkler, K. Kalteis, D. Bikas, M. Rudas, M. Tea, C. Fuerhauser, D. Muhr, H. Cerny, S. Glueck, E. Petru, H. Concin, E. Kubista, P. Oefner, T. Wagner, . (2008) Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group. Journal of Cancer Research and Clinical Oncology 134:10, 1113-1121
CrossRef184
Wei-Tse Yang, Mark Dryden, Kristine Broglio, Michael Gilcrease, Shaheenah Dawood, Peter J. Dempsey, Vicente Valero, Gabriel Hortobagyi, Deann Atchley, Banu Arun. (2008) Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Research and Treatment 111:3, 405-410
CrossRef185
Pedro Pérez Segura, Paula Jiménez, Helena Olivera, Raquel Andrés Conejero, Trinidad Caldés, Miguel Hoya, Jose María Román, Arancha Moreno, Javier Puente, Eduardo Díaz-Rubio. (2008) Risk-reduction surgery in BRCA mutation carriers in a Spanish population: adherence and results. Clinical and Translational Oncology 10:10, 660-664
CrossRef186
Swati K. Basu, Cindy Schwartz, Susan G. Fisher, Melissa M. Hudson, Nancy Tarbell, Ann Muhs, Karen J. Marcus, Nancy Mendenhall, Peter Mauch, Larry E. Kun, Louis S. Constine. (2008) Unilateral and Bilateral Breast Cancer in Women Surviving Pediatric Hodgkin's Disease. International Journal of Radiation Oncology*Biology*Physics 72:1, 34-40
CrossRef187
Claire S. Cooney, Nagi F. Khouri, Theodore N. Tsangaris. (2008) The Role of Breast MRI in the Management of Patients with Breast Disease. Advances in Surgery 42, 299-312
CrossRef188
Ismail Jatoi, William F. Anderson. (2008) Management of Women Who Have a Genetic Predisposition for Breast Cancer. Surgical Clinics of North America 88:4, 845-861
CrossRef189
R. M. Mann, C. K. Kuhl, K. Kinkel, C. Boetes. (2008) Breast MRI: guidelines from the European Society of Breast Imaging. European Radiology 18:7, 1307-1318
CrossRef190
Michael Schaapveld, Otto Visser, W. J. Louwman, Pax H. B. Willemse, Elisabeth G. E. Vries, Winette T. A. Graaf, Renée Otter, Jan Willem W. Coebergh, Flora E. Leeuwen. (2008) The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Research and Treatment 110:1, 189-197
CrossRef191
Ellen Warner. (2008) The Role of Magnetic Resonance Imaging in Screening Women at High Risk of Breast Cancer. Topics in Magnetic Resonance Imaging 19:3, 163-169
CrossRef192
J. Veltman, M. Stoutjesdijk, R. Mann, H. J. Huisman, J. O. Barentsz, J. G. Blickman, C. Boetes. (2008) Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions. European Radiology 18:6, 1123-1133
CrossRef193
Peter R. Eby, Constance D. Lehman. (2008) Magnetic Resonance Imaging-Guided Breast Interventions. Topics in Magnetic Resonance Imaging 19:3, 151-162
CrossRef194
Wendy DeMartini, Constance Lehman. (2008) A Review of Current Evidence-Based Clinical Applications for Breast Magnetic Resonance Imaging. Topics in Magnetic Resonance Imaging 19:3, 143-150
CrossRef195
John W. Gorechlad, Elizabeth B. McCabe, John H. Higgins, Donald S. Likosky, Petra J. Lewis, Kari M. Rosenkranz, Richard J. Barth. (2008) Screening for Recurrences in Patients Treated with Breast-Conserving Surgery: Is there a Role for MRI?. Annals of Surgical Oncology 15:6, 1703-1709
CrossRef196
R. Kaas, S.H. Muller, A.A.M. Hart, E.J.T. Rutgers. (2008) Stage of breast cancers found during the surveillance of women with a familial or hereditary risk. European Journal of Surgical Oncology (EJSO) 34:5, 501-507
CrossRef197
Richard J Santen. (2008) Does menopausal hormone therapy initiate new breast cancers or promote the growth of existing ones?. Women's Health 4:3, 207-210
CrossRef198
Kelly A. Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, William D. Foulkes, Jan Klijn, Eitan Friedman, Charmaine Kim-Sing, Peter Ainsworth, Barry Rosen, Susan Domchek, Teresa Wagner, Nadine Tung, Siranoush Manoukian, Fergus Couch, Ping Sun, Steven A. Narod. (2008) International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. International Journal of Cancer 122:9, 2017-2022
CrossRef199
J. Veltman, R. Mann, T. Kok, I. M. Obdeijn, N. Hoogerbrugge, J. G. Blickman, C. Boetes. (2008) Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI. European Radiology 18:5, 931-938
CrossRef200
Gorane Santamaría, Martín Velasco, Blanca Farrús, Gabriel Zanón, Pedro Luis Fernández. (2008) Preoperative MRI of pure intraductal breast carcinoma—A valuable adjunct to mammography in assessing cancer extent. The Breast 17:2, 186-194
CrossRef201
Takayoshi Uematsu. (2008) Screening and diagnosis of breast cancer in augmented women. Breast Cancer 15:2, 159-164
CrossRef202
Richard J. Bleicher, Neal S. Topham, Monica Morrow. (2008) Beauty and the Beast. Annals of Surgery 247:4, 680-686
CrossRef203
Wendy DeMartini, Constance Lehman, Savannah Partridge. (2008) Breast MRI for Cancer Detection and Characterization. Academic Radiology 15:4, 408-416
CrossRef204
T. Schlossbauer, K. Hellerhoff, M. Reiser. (2008) Wertigkeit der Mamma-MRT als Ergänzung zu Mammographie und Sonographie bei Patientinnen mit erhöhtem Mammakarzinomrisiko. Der Radiologe 48:4, 351-357
CrossRef205
F. Sardanelli, L. Bacigalupo, L. Carbonaro, A. Esseridou, G. M. Giuseppetti, P. Panizza, V. Lattanzio, A. Maschio. (2008) What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard?. La radiologia medica 113:3, 439-451
CrossRef206
Sarah A. McLaughlin, Michelle Stempel, Elizabeth A. Morris, Laura Liberman, Tari A. King. (2008) Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?. Cancer 112:6, 1214-1221
CrossRef207
Sandra Brennan, Lucy E. Hann, Joachim Yahalom, Kevin C. Oeffinger, Jürgen Rademaker. (2008) Imaging of Late Complications from Mantle Field Radiation in Lymphoma Patients. Radiologic Clinics of North America 46:2, 419-430
CrossRef208
Allison W. Kurian, Anne-Renee Hartman, Meredith A. Mills, Laura J. Logan, Anne Marie Sawyer, James M. Ford, Bruce L. Daniel. (2008) Magnetic Resonance Galactography: a Feasibility Study in Women with Prior Atypical Breast Duct Cytology. The Breast Journal 14:2, 211-214
CrossRef209
Holly Janes, Margaret S. Pepe. (2008) Matching in Studies of Classification Accuracy: Implications for Analysis, Efficiency, and Assessment of Incremental Value. Biometrics 64:1, 1-9
CrossRef210
Janet C. Miller, Elizabeth A. Rafferty, Michelle C. Specht, James H. Thrall, Susanna I. Lee. (2008) When Is Breast Magnetic Resonance Imaging Recommended for Cancer Detection?. Journal of the American College of Radiology 5:3, 224-226
CrossRef211
N. Patani, K. Mokbel. (2008) The utility of MRI for the screening and staging of breast cancer. International Journal of Clinical Practice 62:3, 450-453
CrossRef212
Jeanne Yu, Anna Park, Elizabeth Morris, Laura Liberman, Patrick I. Borgen, Tari A. King. (2008) MRI Screening in a Clinic Population with a Family History of Breast Cancer. Annals of Surgical Oncology 15:2, 452-461
CrossRef213
Anna Linda, Chiara Zuiani, Viviana Londero, Massimo Bazzocchi. (2008) Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: Distribution according to patient history of breast cancer and lesion size. The Breast 17:1, 51-57
CrossRef214
G Peters, J Anderson, G Longman, J Thomson, D Taylor, M Bennett, E Wylie, J Goldblatt, A Chan, C Saunders. (2008) Magnetic resonance findings in women at high risk for developing breast cancer: An Australian feasibility study. Journal of Medical Imaging and Radiation Oncology 52:1, 29-35
CrossRef215
M. A. Bollet, N. Servant, P. Neuvial, C. Decraene, I. Lebigot, J.-P. Meyniel, Y. De Rycke, A. Savignoni, G. Rigaill, P. Hupe, A. Fourquet, B. Sigal-Zafrani, E. Barillot, J.-P. Thiery. (2008) High-Resolution Mapping of DNA Breakpoints to Define True Recurrences Among Ipsilateral Breast Cancers. JNCI Journal of the National Cancer Institute 100:1, 48-58
CrossRef216
Ava Kwong, Steven L. Hancock, Joan R. Bloom, Sunita Pal, Robyn L. Birdwell, Carol Mariscal, Debra M. Ikeda. (2008) Mammographic Screening in Women at Increased Risk of Breast Cancer after Treatment of Hodgkin’s Disease. The Breast Journal 14:1, 39-48
CrossRef217
Anthony P. Gulati, Susan M. Domchek. (2008) The clinical management of BRCA1 and BRCA2 mutation carriers. Current Oncology Reports 10:1, 47-53
CrossRef218
Jeon Hor Chen, Byon Feig, Garima Agrawal, Hon Yu, Philip M. Carpenter, Rita S. Mehta, Orhan Nalcioglu, Min Ying Su. (2008) MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer 112:1, 17-26
CrossRef219
Andrew Karellas, Srinivasan Vedantham. (2008) Breast cancer imaging: A perspective for the next decade. Medical Physics 35:11, 4878
CrossRef220
Michael Fatouros, Georgios Baltoyiannis, Dimitrios H. Roukos. (2008) The Predominant Role of Surgery in the Prevention and New Trends in the Surgical Treatment of Women With BRCA1/2 Mutations. Annals of Surgical Oncology 15:1, 21-33
CrossRef221
Kevin R. Fox. (2008) Clinical trials report. Current Oncology Reports 10:1, 7-9
CrossRef222
Byung Ho Son, Sei Hyun Ahn, Min Hyuk Lee, Sue Kyung Park, Sung-Won Kim, . (2008) Hereditary Breast Cancer in Korea: A Review of the Literature. Journal of Breast Cancer 11:1, 1
CrossRef223
Bin Zheng, Margarita L. Zuley, Jules H. Sumkin, Victor J. Catullo, Gordon S. Abrams, Grace Y. Rathfon, Denise M. Chough, Michelle Z. Gruss, David Gur. (2008) Detection of breast abnormalities using a prototype resonance electrical impedance spectroscopy system: A preliminary study. Medical Physics 35:7, 3041
CrossRef224
M KRIEGE. 2008. Screening for Breast Cancer in Women with a Familial or Genetic PredispositionMagnetic Resonance Imaging versus Mammography. , 459-464.
CrossRef225
Joseph W. Carlson, Robyn L. Birdwell, Eva C. Gombos, Mehra Golshan, Darrell N. Smith, Susan C. Lester. (2007) MRI-directed, wire-localized breast excisions: incidence of malignancy and recommendations for pathologic evaluation. Human Pathology 38:12, 1754-1759
CrossRef226
Bernadette A. M. Heemskerk-Gerritsen, Cecile T. M. Brekelmans, Marian B. E. Menke-Pluymers, Albert N. Geel, Madeleine M. A. Tilanus-Linthorst, Carina C. M. Bartels, Murly Tan, Hanne E. J. Meijers-Heijboer, Jan G. M. Klijn, Caroline Seynaeve. (2007) Prophylactic Mastectomy in BRCA1/2 Mutation Carriers and Women at Risk of Hereditary Breast Cancer: Long-Term Experiences at the Rotterdam Family Cancer Clinic. Annals of Surgical Oncology 14:12, 3335-3344
CrossRef227
Sara H. Javid, Joseph W. Carlson, Judy E. Garber, Robyn L. Birdwell, Susan Lester, Stuart Lipsitz, Mehra Golshan. (2007) Breast MRI Wire-Guided Excisional Biopsy: Specimen Size as Compared to Mammogram Wire-Guided Excisional Biopsy and Implications for Use. Annals of Surgical Oncology 14:12, 3352-3358
CrossRef228
Ian G. Murphy, Mary F. Dillon, Ann O' Doherty, Enda W. McDermott, Gabrielle Kelly, Niall O'Higgins, Arnold D.K. Hill. (2007) Analysis of patients with false negative mammography and symptomatic breast carcinoma. Journal of Surgical Oncology 96:6, 457-463
CrossRef229
Davendra Segara, Ian E. Krop, Judy E. Garber, Eric Winer, Lyndsay Harris, Jennifer R. Bellon, Robyn Birdwell, Susan Lester, Stuart Lipsitz, J. Dirk Iglehart, Mehra Golshan. (2007) Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?. Journal of Surgical Oncology 96:6, 474-480
CrossRef230
J A Griffiths, G J Royle, A M Hanby, J A Horrocks, S E Bohndiek, R D Speller. (2007) Correlation of energy dispersive diffraction signatures and microCT of small breast tissue samples with pathological analysis. Physics in Medicine and Biology 52:20, 6151-6164
CrossRef231
Cabot, Richard C.Harris, Nancy Lee, Shepard, Jo-Anne O., Rosenberg, Eric S., Cort, Alice M., Ebeling, Sally H.Peters, Christine C., Winer, Eric P., Harris, Jay R., Smith, Barbara L., D'Alessandro, Helen Anne, Brachtel, Elena F., . (2007) Case 32-2007. New England Journal of Medicine 357:16, 1640-1648
Full Text232
(2007) Management of an Inherited Predisposition to Breast Cancer. New England Journal of Medicine 357:16, 1663-1663
Full Text233
Angela R. Bradbury, Olufunmilayo I. Olopade. (2007) Genetic susceptibility to breast cancer. Reviews in Endocrine and Metabolic Disorders 8:3, 255-267
CrossRef234
Dimitrios H Roukos, Evangelos Briasoulis. (2007) Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome. Nature Clinical Practice Oncology 4:10, 578-590
CrossRef235
Mark E. Robson. (2007) Treatment of Hereditary Breast Cancer. Seminars in Oncology 34:5, 384-391
CrossRef236
Peter R. Eby, Wendy B. DeMartini, Sue Peacock, Eric L. Rosen, Bridget Lauro, Constance D. Lehman. (2007) Cancer yield of probably benign breast MR examinations. Journal of Magnetic Resonance Imaging 26:4, 950-955
CrossRef237
Rebecca Dent, Ellen Warner. (2007) Screening for Hereditary Breast Cancer. Seminars in Oncology 34:5, 392-400
CrossRef238
Federica Pediconi, Carlo Catalano, Simona Padula, Antonella Roselli, Enrica Moriconi, Valeria Dominelli, Anna Maria Pronio, Miles A. Kirchin, Roberto Passariello. (2007) Contrast-enhanced magnetic resonance mammography: does it affect surgical decision-making in patients with breast cancer?. Breast Cancer Research and Treatment 106:1, 65-74
CrossRef239
Dalliah Black, Michelle Specht, Janie M. Lee, Francisco Dominguez, Michele Gadd, Kevin Hughes, Elizabeth Rafferty, Barbara Smith. (2007) Detecting Occult Malignancy in Prophylactic Mastectomy: Preoperative MRI Versus Sentinel Lymph Node Biopsy. Annals of Surgical Oncology 14:9, 2477-2484
CrossRef240
K. Pieterse, S. van Dooren, C. Seynaeve, C.C.M. Bartels, A.J. Rijnsburger, H.J. de Koning, J.G.M. Klijn, T. van Elderen, A. Tibben, H.J. Duivenvoorden. (2007) Passive coping and psychological distress in women adhering to regular breast cancer surveillance. Psycho-Oncology 16:9, 851-858
CrossRef241
Wendie A. Berg. (2007) Beyond Standard Mammographic Screening: Mammography at Age Extremes, Ultrasound, and MR Imaging. Radiologic Clinics of North America 45:5, 895-906
CrossRef242
(2007) Canadian Association of General Surgeons and ACS, Evidence-Based Reviews in Surgery. Journal of the American College of Surgeons 205:3, 498-500
CrossRef243
Elizabeth A. Morris. (2007) Diagnostic Breast MR Imaging: Current Status and Future Directions. Radiologic Clinics of North America 45:5, 863-880
CrossRef244
A. Linda, V. Londero, F. Mazzarella, C. Zuiani, M. Bazzocchi. (2007) Rare breast neoplasms: is there any peculiar feature on magnetic resonance mammography?. La radiologia medica 112:6, 850-862
CrossRef245
Pal Moller, D. Gareth Evans, Marta M. Reis, Helen Gregory, Elaine Anderson, Lovise Maehle, Fiona Lalloo, Anthony Howell, Jaran Apold, Neal Clark, Anneke Lucassen, C. Michael Steel. (2007) Surveillance for familial breast cancer: Differences in outcome according toBRCA mutation status. International Journal of Cancer 121:5, 1017-1020
CrossRef246
Laura J Esserman, Yiwey Shieh, John W Park, Elissa M Ozanne. (2007) A role for biomarkers in the screening and diagnosis of breast cancer in younger women. Expert Review of Molecular Diagnostics 7:5, 533-544
CrossRef247
(2007) Practice Guideline for the Breast Conservation Therapy in the Management of Invasive Breast Carcinoma. Journal of the American College of Surgeons 205:2, 362-376.e2
CrossRef248
Subhadra Srinivasan, Brian W. Pogue, Colin Carpenter, Shudong Jiang, Wendy A. Wells, Steven P. Poplack, Peter A. Kaufman, Keith D. Paulsen. (2007) Developments in Quantitative Oxygen-Saturation Imaging of Breast Tissue In Vivo Using Multispectral Near-Infrared Tomography. Antioxidants & Redox Signaling 9:8, 1143-1156
CrossRef249
Anne I. Hagen, Kjell Arne Kvistad, Lovise Maehle, Marit Muri Holmen, Hildegunn Aase, Bodil Styr, Anita Vabø, Jaran Apold, Per Skaane, Pål Møller. (2007) Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. The Breast 16:4, 367-374
CrossRef250
Christiane K Kuhl, Simone Schrading, Heribert B Bieling, Eva Wardelmann, Claudia C Leutner, Roy Koenig, Walther Kuhn, Hans H Schild. (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. The Lancet 370:9586, 485-492
CrossRef251
S. Pruthi, K. R. Brandt, A. C. Degnim, M. P. Goetz, E. A. Perez, C. A. Reynolds, P. J. Schomberg, G. K. Dy, J. N. Ingle. (2007) A Multidisciplinary Approach to the Management of Breast Cancer, Part 1: Prevention and Diagnosis. Mayo Clinic Proceedings 82:8, 999-1012
CrossRef252
Robson, Mark, Offit, Kenneth, . (2007) Management of an Inherited Predisposition to Breast Cancer. New England Journal of Medicine 357:2, 154-162
Full Text253
Janice L. Berliner, Angela Musial Fay. (2007) Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian Cancer: Recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling 16:3, 241-260
CrossRef254
Catherine Ruhl. (2007) Breast Health Screening: What All Women Should Know. Nursing for Women's Health 11:3, 326-330
CrossRef255
Pejman Ghanouni, Allison W. Kurian, Daniel Margolis, Anne-Renee Hartman, Meredith A. Mills, Sylvia K. Plevritis, James M. Ford, Bruce L. Daniel. (2007) Ductal Pattern Enhancement on Magnetic Resonance Imaging of the Breast Due to Ductal Lavage. The Breast Journal 13:3, 281-286
CrossRef256
Giampiero Capobianco, Bernardino Spaliviero, Salvatore Dessole, Paolo Cossu Rocca, Pier Luigi Cherchi, Guido Ambrosini, Francesco Meloni, Giovanni Battista Meloni. (2007) Lymph Node Axillary Metastasis from Occult Contralateral Infiltrating Lobular Carcinoma Arising in Accessory Breast: MRI Diagnosis. The Breast Journal 13:3, 305-307
CrossRef257
Francesco Sardanelli, Franca Podo. (2007) Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?. European Radiology 17:4, 873-887
CrossRef258
Smith, Robert A., . (2007) The Evolving Role of MRI in the Detection and Evaluation of Breast Cancer. New England Journal of Medicine 356:13, 1362-1364
Full Text259
Lehman, Constance D., Gatsonis, Constantine, Kuhl, Christiane K., Hendrick, R. Edward, Pisano, Etta D., Hanna, Lucy, Peacock, Sue, Smazal, Stanley F., Maki, Daniel D., Julian, Thomas B., DePeri, Elizabeth R., Bluemke, David A., Schnall, Mitchell D., . (2007) MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer. New England Journal of Medicine 356:13, 1295-1303
Full Text260
M. Kriege, C. T. M. Brekelmans, H. Peterse, I. M. Obdeijn, C. Boetes, H. M. Zonderland, S. H. Muller, T. Kok, R. A. Manoliu, A. P. E. Besnard, M. M. A. Tilanus-Linthorst, C. Seynaeve, C. C. M. Bartels, S. Meijer, J. C. Oosterwijk, N. Hoogerbrugge, R. A. E. M. Tollenaar, H. J. Koning, E. J. T. Rutgers, J. G. M. Klijn. (2007) Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer. Breast Cancer Research and Treatment 102:3, 357-363
CrossRef261
S. Eva Singletary. (2007) Multidisciplinary frontiers in breast cancer management. Cancer 109:6, 1019-1029
CrossRef262
Gemma Llort, Mercè Peris, Ignacio Blanco. (2007) Cáncer de mama y ovario hereditario: prevención primaria y secundaria en mujeres portadoras de mutación en los genes BRCA1 y BRCA2. Medicina Clínica 128:12, 468-476
CrossRef263
Elisa Rush Port, Anna Park, Patrick I. Borgen, Elizabeth Morris, Leslie L. Montgomery. (2007) Results of MRI Screening for Breast Cancer in High-Risk Patients with LCIS and Atypical Hyperplasia. Annals of Surgical Oncology 14:3, 1051-1057
CrossRef264
Nehmat Houssami, Robin Wilson. (2007) Should women at high risk of breast cancer have screening magnetic resonance imaging (MRI)?. The Breast 16:1, 2-4
CrossRef265
J Gronwald, T Byrski, T Huzarski, C Cybulski, M Stawicka, M Szwiec, T Dębniak, A Tulman, P Sun, O Oszurek, J Lubinski, SA Narod. (2007) A survey of preventive measures among BRCA1 mutation carriers from Poland. Clinical Genetics 71:2, 153-157
CrossRef266
Anne A. Tardivon, Alexandra Athanasiou, Fabienne Thibault, Carl El Khoury. (2007) Breast imaging and reporting data system (BIRADS): Magnetic resonance imaging. European Journal of Radiology 61:2, 212-215
CrossRef267
WE Hadden. (2007) Recommendations for the surveillance of young women at increased risk for breast cancer. Australasian Radiology 51:1, 1-11
CrossRef268
Fabienne Patricia Liebens, Birgit Carly, Ann Pastijn, Serge Rozenberg. (2007) Management of BRCA1/2 associated breast cancer: A systematic qualitative review of the state of knowledge in 2006. European Journal of Cancer 43:2, 238-257
CrossRef269
&NA;. (2007) Evidence that High Calcium and Vitamin D Intake Decrease the Risk of Breast Cancer in Premenopausal Women: Implications for Breast Cancer Prevention and Screening :. Southern Medical Journal 100:11, 1061
CrossRef270
Catherine S. Klifa, Ann Shimakawa, Zaker Siraj, Jessica E. Gibbs, Lisa J. Wilmes, Savannah C. Partridge, Evelyn Proctor, Nola M. Hylton. (2007) Characterization of breast lesions using the 3D FIESTA sequence and contrast-enhanced magnetic resonance imaging. Journal of Magnetic Resonance Imaging 25:1, 82-88
CrossRef271
Lia Bartella, Clare S. Smith, D. David Dershaw, Laura Liberman. (2007) Imaging Breast Cancer. Radiologic Clinics of North America 45:1, 45-67
CrossRef272
C. Comstock. (2007) 4–12 Diagnostic Architectural and Dynamic Features at Breast MR Imaging: Multicenter Study. Breast Diseases: A Year Book Quarterly 17:4, 344-345
CrossRef273
Seiko KUROKI-SUZUKI, Yoshifumi KUROKI, Katsuhiro NASU, Shigeru NAWANO, Noriyuki MORIYAMA, Masatoshi OKAZAKI. (2007) Detecting Breast Cancer with Non-contrast MR Imaging: Combining Diffusion-weighted and STIR Imaging. Magnetic Resonance in Medical Sciences 6:1, 21-27
CrossRef274
Michael K. O'Connor, Stephen W. Phillips, Carrie B. Hruska, Deborah J. Rhodes, Douglas A. Collins. (2007) Molecular Breast Imaging: Advantages and Limitations of a Scintimammographic Technique in Patients with Small Breast Tumors. The Breast Journal 13:1, 3-11
CrossRef275
Jennifer Scalia Wilbur, Adam A. Rojan, Robert D. Legare. 2007. The Genetics of Breast and Gynecologic Cancers. , 43-71.
CrossRef276
Louise J. Bordeleau, Joan E. Lipa, Peter C. Neligan. (2007) Management of the BRCA Mutation Carrier or High-Risk Patient. Clinics in Plastic Surgery 34:1, 15-27
CrossRef277
Yoland C. Antill, John Reynolds, Mary Anne Young, ˙ Judy A. Kirk, Katherine M. Tucker, Tarli L. Bogtstra, ˙ Shirley S. Wong, ˙ Tracy E. Dudding, Juliana L. Di Iulio, Kelly-Anne Phillips. (2006) Screening behavior in women at increased familial risk for breast cancer. Familial Cancer 5:4, 359-368
CrossRef278
Rita K. Schmutzler, Kerstin Rhiem, Petra Breuer, Eva Wardelmann, Martin Lehnert, Silke Coburger, Barbara Wappenschmidt. (2006) Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer. European Journal of Cancer Prevention 15:6, 483-489
CrossRef279
John M. Quillin, Donna K. McClish, Resa M. Jones, Karen Burruss, Joann N. Bodurtha. (2006) Spiritual Coping, Family History, and Perceived Risk for Breast Cancer—Can We Make Sense of it?. Journal of Genetic Counseling 15:6, 449-460
CrossRef280
Nicola Roche. (2006) Follow-up after treatment for breast cancer in young women. The Breast 15, S71-S75
CrossRef281
John M. Boone, Alex L. C. Kwan, Kai Yang, George W. Burkett, Karen K. Lindfors, Thomas R. Nelson. (2006) Computed Tomography for Imaging the Breast. Journal of Mammary Gland Biology and Neoplasia 11:2, 103-111
CrossRef282
M. Van Goethem, W. Tjalma, K. Schelfout, I. Verslegers, I. Biltjes, P. Parizel. (2006) Magnetic resonance imaging in breast cancer. European Journal of Surgical Oncology (EJSO) 32:9, 901-910
CrossRef283
Alan Penn, Scott Thompson, Rachel Brem, Constance Lehman, Paul Weatherall, Mitchell Schnall, Gillian Newstead, Emily Conant, Susan Ascher, Elizabeth Morris, Etta Pisano. (2006) Morphologic Blooming in Breast MRI as a Characterization of Margin for Discriminating Benign from Malignant Lesions. Academic Radiology 13:11, 1344-1354
CrossRef284
Constance D. Lehman. (2006) Role of MRI in screening women at high risk for breast cancer. Journal of Magnetic Resonance Imaging 24:5, 964-970
CrossRef285
Petra Viehweg, Thorsten Bernerth, Anke Heinig, Marion Kiechle, Jörg Buchmann, Heinz Koelbl, Michael Laniado, Sylvia Helen Heywang-Köbrunner. (2006) MR-Guided Intervention in Women at High Hereditary Risk of Breast Cancer Due to both Family and Personal History of Breast Cancer. The Breast Journal 12:6, 549-558
CrossRef286
Kent F. Hoskins, Alice Zwaagstra, Michael Ranz. (2006) Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer 107:8, 1769-1776
CrossRef287
Mieke Kriege, Cecile T. M. Brekelmans, Inge Marie Obdeijn, Carla Boetes, Harmine M. Zonderland, Sara H. Muller, Theo Kok, Radu A. Manoliu, A. Peter E. Besnard, Madeleine M. A. Tilanus-Linthorst, Caroline Seynaeve, Carina C. M. Bartels, Reini Kaas, Siebren Meijer, Jan C. Oosterwijk, Nicoline Hoogerbrugge, Rob A. E. M. Tollenaar, Emiel J. T. Rutgers, Harry J. Koning, Jan G. M. Klijn. (2006) Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast Cancer. Breast Cancer Research and Treatment 100:1, 109-119
CrossRef288
I Griebsch, J Brown, C Boggis, A Dixon, M Dixon, D Easton, R Eeles, D G Evans, F J Gilbert, J Hawnaur, P Kessar, S R Lakhani, S M Moss, A Nerurkar, A R Padhani, L J Pointon, J Potterton, D Thompson, L W Turnbull, L G Walker, R Warren, M O Leach. (2006) Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. British Journal of Cancer 95:7, 801-810
CrossRef289
M.L. Essink-Bot, A.J. Rijnsburger, S. van Dooren, H.J. de Koning, C. Seynaeve. (2006) Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition. The Breast 15:5, 673-676
CrossRef290
S M Domchek, B L Weber. (2006) Clinical management of BRCA1 and BRCA2 mutation carriers. Oncogene 25:43, 5825-5831
CrossRef291
Brenda B.J. Hermsen, Paul J. van Diest, Johannes Berkhof, Fred H. Menko, Johan J.P. Gille, Jurgen M.J. Piek, Sybren Meijer, Henri A.H. Winters, Peter Kenemans, Silvia von Mensdorff-Pouilly, René H.M. Verheijen. (2006) Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer. International Journal of Cancer 119:6, 1412-1418
CrossRef292
P. NEVEN, I. VERGOTE, F. AMANT, P. BERTELOOT, E. de JONGE, C. DE ROP, P. DE SUTTER, A. MAKAR, J. VAN GINDERACHTER. (2006) Endocrine Treatment and Prevention of Breast and Gynecological Cancers Vth International Symposium of the Flemish Gynecological Oncology Group, January 26?28, 2006. International Journal of Gynecological Cancer 16:s2, 479-491
CrossRef293
Hiroyoshi Doihara, Takeo Fujita, Daisuke Takabatake, Hirotoshi Takahashi, Yutaka Ogasawara, Nobuyoshi Shimizu. (2006) Clinical Significance of Multidetector-Row Computed Tomography in Breast Surgery. The Breast Journal 12:s2, S204-S209
CrossRef294
M. A. A. J. Bosch, B. L. Daniel, S. Pal, K. W. Nowels, R. L. Birdwell, S. S. Jeffrey, D. M. Ikeda. (2006) MRI-guided needle localization of suspicious breast lesions: results of a freehand technique. European Radiology 16:8, 1811-1817
CrossRef295
Richard Werner, Sascha Krueger, Axel Winkel, Christoph Albrecht, Tobias Schaeffter, Martin Heller, Christian Frahm. (2006) MR-guided breast biopsy using an active marker: A phantom study. Journal of Magnetic Resonance Imaging 24:1, 235-241
CrossRef296
Dževad Belkić, Karen Belkić. (2006) Mathematical Optimization of in vivo NMR Chemistry Through the Fast Padé Transform: Potential Relevance for Early Breast Cancer Detection by Magnetic Resonance Spectroscopy. Journal of Mathematical Chemistry 40:1, 85-103
CrossRef297
Richard Tuli, Ryan A. Flynn, Kristin L. Brill, Jennifer L. Sabol, Kenneth Y. Usuki, Anne L. Rosenberg. (2006) Diagnosis, Treatment, and Management of Breast Cancer in Previously Augmented Women. The Breast Journal 12:4, 343-348
CrossRef298
Wendie A. Berg, Irving N. Weinberg, Deepa Narayanan, Mary E. Lobrano, Eric Ross, Laura Amodei, Lorraine Tafra, Lee P. Adler, Joseph Uddo, William Stein, Edward A. Levine, . (2006) High-Resolution Fluorodeoxyglucose Positron Emission Tomography with Compression ("Positron Emission Mammography") is Highly Accurate in Depicting Primary Breast Cancer. The Breast Journal 12:4, 309-323
CrossRef299
Mieke Kriege, Cecile T. M. Brekelmans, Carla Boetes, Sara H. Muller, Harmine M. Zonderland, Inge Marie Obdeijn, Radu A. Manoliu, Theo Kok, Emiel J. T. Rutgers, Harry J. de Koning, Jan G. M. Klijn, . (2006) Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer 106:11, 2318-2326
CrossRef300
A. J. Rijnsburger, M. L. Essink-Bot, E. As, J. Cockburn, H. J. Koning. (2006) Measuring Psychological Consequences of Screening: Adaptation of the Psychological Consequences Questionnaire into Dutch. Quality of Life Research 15:5, 933-940
CrossRef301
Alexander Stojadinovic, Orah Moskovitz, Zahava Gallimidi, Scott Fields, Ari D. Brooks, Rachel Brem, Robert N. Mucciola, Mukul Singh, Mary Maniscalco-Theberge, Howard E. Rockette, David Gur, Craig D. Shriver. (2006) Prospective study of electrical impedance scanning for identifying young women at risk for breast cancer. Breast Cancer Research and Treatment 97:2, 179-189
CrossRef302
E Winchester, Shirley V Hodgson. (2006) Psychosocial and ethical issues relating to genetic testing for BRCA1 and BRCA2 breast cancer susceptibility genes. Women's Health 2:3, 357-373
CrossRef303
Vanessa Blair, Iain Martin, David Shaw, Ingrid Winship, Dale Kerr, Julie Arnold, Pauline Harawira, Maybelle McLeod, Susan Parry, Amanda Charlton, Michael Findlay, Brian Cox, Bostjan Humar, Helen More, Parry Guilford. (2006) Hereditary Diffuse Gastric Cancer: Diagnosis and Management. Clinical Gastroenterology and Hepatology 4:3, 262-275
CrossRef304
Josep M. Sabaté, Antonio Gómez, Sofía Torrubia, Carme Blancas, Gloria Sánchez, M. C. Alonso, E. Lerma. (2006) Evaluation of breast involvement in relation to Cowden syndrome: a radiological and clinicopathological study of patients with PTEN germ-line mutations. European Radiology 16:3, 702-706
CrossRef305
Lia Bartella, Elizabeth A. Morris. (2006) Advances in breast imaging: Magnetic resonance imaging. Current Oncology Reports 8:1, 7-13
CrossRef306
Serhan Tuncer, Gustavo Bello-Rojas, Camelia Ratiu, Ian T. Jackson. (2006) Reduction mammaplasty in the previously radiated breast: is it safe and does it interfere oncologically?. European Journal of Plastic Surgery 28:6, 412-417
CrossRef307
Michael P. Lux, Peter A. Fasching, Matthias W. Beckmann. (2006) Hereditary breast and ovarian cancer: review and future perspectives. Journal of Molecular Medicine 84:1, 16-28
CrossRef308
Karen Lisa Smith, Mark E. Robson. (2006) Update on hereditary breast cancer. Current Oncology Reports 8:1, 14-21
CrossRef309
Almut Artmann, Karin Hellerhoff, Sylvia H. Heywang-Köbrunner. (2006) Screening in Women with Increased Breast Cancer Risk. Breast Care 1:1, 22-25
CrossRef310
P. Viehweg, T. Bernerth, M. Kiechle, J. Buchmann, A. Heinig, H. Koelbl, M. Laniado, S.H. Heywang-Köbrunner. (2006) MR-guided intervention in women with a family history of breast cancer. European Journal of Radiology 57:1, 81-89
CrossRef311
Marzia Palma, Elisabetta Ristori, Enrico Ricevuto, Giuseppe Giannini, Alberto Gulino. (2006) BRCA1 and BRCA2: The genetic testing and the current management options for mutation carriers. Critical Reviews in Oncology/Hematology 57:1, 1-23
CrossRef312
Rebecca Rakow-Penner, Bruce Daniel, Huanzhou Yu, Anne Sawyer-Glover, Gary H. Glover. (2006) Relaxation times of breast tissue at 1.5T and 3T measured using IDEAL. Journal of Magnetic Resonance Imaging 23:1, 87-91
CrossRef313
Charlotte H. Clarke, Julie A. Buckley, Eric T. Fung. (2005) SELDI-TOF-MS proteomics of breast cancer. Clinical Chemistry and Laboratory Medicine 43:12, 1314-1320
CrossRef314
C.K. Kuhl, W. Kuhn, H. Schild. (2005) Management of women at high risk for breast cancer: New imaging beyond mammography. The Breast 14:6, 480-486
CrossRef315
Claire L. Buchanan, Elizabeth A. Morris, Paige L. Dorn, Patrick I. Borgen, Kimberly J. Zee. (2005) Utility of Breast Magnetic Resonance Imaging in Patients With Occult Primary Breast Cancer. Annals of Surgical Oncology 12:12, 1045-1053
CrossRef316
Jeffery Peppercorn, Ann Partridge, Harold J. Burstein, Eric P. Winer. (2005) Standards for follow-up care of patients with breast cancer. The Breast 14:6, 500-508
CrossRef317
S. Lenz. (2005) Detecting breast cancer: evidence for the significance of the mostly used methods. European Clinics in Obstetrics and Gynaecology 1:3, 171-176
CrossRef318
Kristina Allen-Brady, Nicola J. Camp, John H. Ward, Lisa A. Cannon-Albright. (2005) Lobular breast cancer: Excess familiality observed in the Utah Population Database. International Journal of Cancer 117:4, 655-661
CrossRef319
Francisco J. Dominguez, Julie L. Jones, Katherina Zabicki, Barbara L. Smith, Michele A. Gadd, Michele Specht, Daniel B. Kopans, Richard H. Moore, James S. Michaelson, Kevin S. Hughes. (2005) Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population. Cancer 104:9, 1849-1853
CrossRef320
Steven E. Harms. (2005) The Use of Breast Magnetic Resonance Imaging in Ductal Carcinoma in Situ. The Breast Journal 11:6, 379-381
CrossRef321
LeAnn Beran, Wen Liang, Tom Nims, Jean Paquelet, Brenda Sickle-Santanello. (2005) Correlation of targeted ultrasound with magnetic resonance imaging abnormalities of the breast. The American Journal of Surgery 190:4, 592-594
CrossRef322
Michelle N. Mariano, Maurice A.A.J. van den Bosch, Bruce L. Daniel, Kent W. Nowels, Robyn L. Birdwell, Kathy J. Fong, Pam S. Desmond, Sylvia Plevritis, Lara A. Stables, Marowan Zakhour, Robert J. Herfkens, Debra M. Ikeda. (2005) Contrast-enhanced MRI of ductal carcinoma in situ: Characteristics of a new intensity-modulated parametric mapping technique correlated with histopathologic findings. Journal of Magnetic Resonance Imaging 22:4, 520-526
CrossRef323
Heather Wright, Jay Listinsky, Alice Rim, Melanie Chellman-Jeffers, Rebecca Patrick, Lisa Rybicki, Julian Kim, Joseph Crowe. (2005) Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women. The American Journal of Surgery 190:4, 572-575
CrossRef324
Samantha A. Langer, Kathleen C. Horst, Debra M. Ikeda, Bruce L. Daniel, Christina S. Kong, Frederick M. Dirbas. (2005) Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy?. The American Journal of Surgery 190:4, 633-640
CrossRef325
Allison W. Kurian, Anne-Renee Hartman, Meredith A. Mills, James M. Ford, Bruce L. Daniel, Sylvia K. Plevritis. (2005) Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. Health Expectations 8:3, 221-233
CrossRef326
Ismail Jatoi, William F. Anderson. (2005) Cancer Screening. Current Problems in Surgery 42:9, 620-682
CrossRef327
Edna Furman-Haran, Edna Schechtman, Frederick Kelcz, Kevin Kirshenbaum, Hadassa Degani. (2005) Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions. Cancer 104:4, 708-718
CrossRef328
Dione M. Farria, Maria E. Schmidt, Barbara S. Monsees, Robert A. Smith, Charles Hildebolt, Roberta Yoffie, Debra L. Monticciolo, Stephen A. Feig, Lawrence W. Bassett. (2005) Professional and economic factors affecting access to mammography: A crisis today, or tomorrow?. Cancer 104:3, 491-498
CrossRef329
Maurice A.A.J. van den Bosch, Bruce L. Daniel. (2005) MR-Guided Interventions of the Breast. Magnetic Resonance Imaging Clinics of North America 13:3, 505-517
CrossRef330
Peter Mauch, Andrea Ng, Berthe Aleman, Patrice Carde, Louis Constine, Volker Diehl, Ketayun Dinshaw, Mary Gospodarowicz, Steve Hancock, David Hodgson, Richard Hoppe, Raymond Liang, Markus Loeffler, Lena Specht, Lois B. Travis, Andrew Wirth, Joachim Yahalom. (2005) Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9-16, 2003, Bellagio, Italy. European Journal of Haematology 75, 68-76
CrossRef331
Steven A Narod. (2005) Clinical implications of the breast cancer susceptibility genes BRCA1 and BRCA2. Women's Health 1:1, 27-34
CrossRef332
Madeleine M Tilanus-Linthorst, Inge-Marie Obdeijn, Karina CM Bartels. (2005) MARIBS study. The Lancet 366:9482, 291-292
CrossRef333
Wendy B. DeMartini, Constance D. Lehman, Sue Peacock, Mai T. Russell. (2005) Computer-Aided Detection Applied to Breast MRI: Assessment of CAD-Generated Enhancement and Tumor Sizes in Breast Cancers Before and After Neoadjuvant Chemotherapy1. Academic Radiology 12:7, 806-814
CrossRef334
Takeo Fujita, Hiroyoshi Doihara, Daisuke Takabatake, Hirotoshi Takahashi, Seiji Yoshitomi, Yoichi Ishibe, Yutaka Ogasawara, Nobuyoshi Shimizu. (2005) Multidetector row computed tomography for diagnosing intraductal extension of breast carcinoma. Journal of Surgical Oncology 91:1, 10-16
CrossRef335
Dorothee R. Fischer, Susanne Wurdinger, Joachim Boettcher, Ansgar Malich, Werner A. Kaiser. (2005) Further Signs in the Evaluation of Magnetic Resonance Mammography. Investigative Radiology 40:7, 430-435
CrossRef336
L SIM, J HENDRIKS, P BULT, S FOOKCHONG. (2005) US correlation for MRI-detected breast lesions in women with familial risk of breast cancer. Clinical Radiology 60:7, 801-806
CrossRef337
Henry T. Lynch, William Grady, Gianpaolo Suriano, David Huntsman. (2005) Gastric cancer: New genetic developments. Journal of Surgical Oncology 90:3, 114-133
CrossRef338
M. Kriege, C. T. M. Brekelmans, J. G. M. Klijn. (2005) MRI Screening for Breast Cancer in Women with a Familial or Genetic Predisposition. Imaging Decisions MRI 9:2, 11-18
CrossRef339
Mark J. Stoutjesdijk, Jurgen J. F??tterer, Carla Boetes, Lya E. van Die, Gerrit Jager, Jelle O. Barentsz. (2005) Variability in the Description of Morphologic and Contrast Enhancement Characteristics of Breast Lesions onMagnetic Resonance Imaging. Investigative Radiology 40:6, 355-362
CrossRef340
D. Thompson, S. Duedal, J. Kirner, L. McGuffog, J. Last, A. Reiman, P. Byrd, M. Taylor, D. F. Easton. (2005) Cancer Risks and Mortality in Heterozygous ATM Mutation Carriers. JNCI Journal of the National Cancer Institute 97:11, 813-822
CrossRef341
F.J. Gilbert. (2005) Screening for breast cancer in women at moderate and high risk. Clinical Oncology 17:4, 240-243
CrossRef342
E. V. Moiseeva, E. M. Rapoport, N. V. Bovin, A. I. Miroshnikov, A. V. Chaadaeva, M. S. Krasilshschikova, V. K. Bojenko, Caspaar Bijleveld, J. E. van Dijk, W. Den Otter. (2005) Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer. Breast Cancer Research and Treatment 91:3, 227-241
CrossRef343
Paul Friedman, Linda Sanders, Joe Russo, Ron Sharo, Srirama Swaminathan, Robert Smith. (2005) Detection and Localization of Occult Lesions Using Breast Magnetic Resonance Imaging. Academic Radiology 12:6, 728-738
CrossRef344
David Gurwitz. (2005) Workshop Abstracts. Personalized Medicine 2:2, 145-185
CrossRef345
Constance D. Lehman, Jeffrey D. Blume, Paul Weatherall, David Thickman, Nola Hylton, Ellen Warner, Etta Pisano, Stuart J. Schnitt, Constantine Gatsonis, Mitchell Schnall, . (2005) Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103:9, 1898-1905
CrossRef346
Alan Dardik. (2005) Use of Magnetic Resonance Imaging in Breast Oncology. Journal of the American College of Surgeons 200:5, 742
CrossRef347
Ellen Warner, Petrina A Causer. (2005) MRI surveillance for hereditary breast-cancer risk. The Lancet 365:9473, 1747-1749
CrossRef348
Jiani Hu, Stephen A. Vartanian, Yang Xuan, Zahid Latif, Renate L. Soulen. (2005) An improved 1H magnetic resonance spectroscopic imaging technique for the human breast: preliminary results. Magnetic Resonance Imaging 23:4, 571-576
CrossRef349
(2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). The Lancet 365:9473, 1769-1778
CrossRef350
Denise H. Reddy, Ellen B. Mendelson. (2005) Incorporating new imaging models in breast cancer management. Current Treatment Options in Oncology 6:2, 135-145
CrossRef351
Anne Marie Wallace, Bruce L. Daniel, Stefanie S. Jeffrey, Robyn L. Birdwell, Kent W. Nowels, Frederick M. Dirbas, Pamela Schraedley-Desmond, Debra M. Ikeda. (2005) Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization. Journal of the American College of Surgeons 200:4, 527-537
CrossRef352
Anwar R Padhani, Mei-Lin W Ah-See, Andreas Makris. (2005) MRI in the detection and management of breast cancer. Expert Review of Anticancer Therapy 5:2, 239-252
CrossRef353
G. V. Babiera. (2005) Surgical considerations for breast-conserving therapy in patients undergoing neoadjuvant chemotherapy for early-stage breast cancer. Breast Cancer Online 8:02,
CrossRef354
W Brian Hyslop, Richard C Semelka. (2005) Future Directions in Body Magnetic Resonance Imaging. Topics in Magnetic Resonance Imaging 16:1, 3-14
CrossRef355
Powel Brown. (2005) Risk Assessment: Controversies and Management of Moderate- to High-Risk Individuals. The Breast Journal 11:s1, S11-S19
CrossRef356
Douglas B. Zippel, Moshe Z. Papa. (2005) The use of MR imaging guided focused ultrasound in breast cancer patients; a preliminary phase one study and review. Breast Cancer 12:1, 32-38
CrossRef357
M. Medlej-Hashim, A. Mégarbané. (2005) Le diagnostic présymptomatique des maladies graves héréditaires à révélation tardive au Liban : un choix ou une nécessité ?. Santé Publique 17:4, 617
CrossRef358
Deborah J. Rhodes, Michael K. O'Connor, Stephen W. Phillips, Robin L. Smith, Douglas A. Collins. (2005) Molecular Breast Imaging: A New Technique Using Technetium Tc 99m Scintimammography to Detect Small Tumors of the Breast. Mayo Clinic Proceedings 80:1, 24-30
CrossRef359
K. G. A. Gilhuijs, E. E. Deurloo. (2004) MRI in familial breast cancer. Breast Cancer Online 7:12,
CrossRef360
Niki J. Agnantis, Evangelos Paraskevaidis, Dimitrios Roukos. (2004) Preventing Breast, Ovarian Cancer in BRCA Carriers: Rational of Prophylactic Surgery and Promises of Surveillance. Annals of Surgical Oncology 11:12, 1030-1034
CrossRef361
(2004) MRI in Breast Cancer. New England Journal of Medicine 351:21, 2235-2236
Full Text362
C. J. Fabian, B. F. Kimler, M. S. Mayo. (2004) Ductal Lavage for Early Detection--What Doesn't Come Out in the Wash. JNCI Journal of the National Cancer Institute 96:20, 1488-1489
CrossRef363
Christiane K. Kuhl. (2004) Screening of Women with Hereditary Risk of Breast Cancer. Clinical Breast Cancer 5:4, 269-271
CrossRef364
Martin J Yaffe. (2004) What should the burden of proof be for acceptance of a new breast-cancer screening technique?. The Lancet 364:9440, 1111-1112
CrossRef365
Liberman, Laura, . (2004) Breast Cancer Screening with MRI — What Are the Data for Patients at High Risk?. New England Journal of Medicine 351:5, 497-500
Full Text
- Letters
